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ABSTRACT 
The possible role of endonuclease and protein synthesis inhibition by aunn 
tricarboxylic acid (ATA) and by cycloheximide (CHX) respectively was investigated in 
sanguinarine induced apoptosis (PCD) and blister cell death (BCD) in KS62 
erythroleukemia cells. 
Studies in our laboratory have consistently shown that when KS62 cells are 
treated with sanguinarine- a quaternary benzophenanthridine alkaloid which is reported to 
inhibit protein kinase C and nuclear factor NF-KB, at concentrations of 1.5 f..t.g/ml for 2hrs 
induced the morphology of PCD, and at concentrations of 12.5 J.!.g/ml for 2 hrs the 
morphology of BCD (blister formation). This phenomenon of dual cell death modality 
was termed "bimodal cell death" or BMCD (Liepins et al., 1996). 
The role of endonuclease activity and protein synthesis in PCD and BCD was 
assessed by the capacity of AT A and CHX respectively, to inhibit these processes. This 
was investigated by pretreating cells with AT A and CHX prior to sanguinarine treatment 
and subsequently measuring their effects on bimodal cell death using a host of standard 
methods: light microscopy and quantitative morphology; electron microscopy; terminal 
dUTP mediated nick end labelling (TUNEL) assay; annexin V binding assay 
(fluorescence microscopic and flow cytometric analysis); 51Cr release assay; DNA 
content analysis by flowcytometry; oxygen consumption studies; trypan blue assay. 
Results show that, while AT A pretreatment of cells inhibited PCD almost completely and 
BCD by 30-40%, CHX pretreatment failed to inhibit PCD and BCD. This may indicate 
the importance of endonuclease in sanguinarine induced PCD and to some extent in 
ii 
BCD. This may also signify the importance of post-translational modification of proteins 
rather than their de novo synthesis in both these forms of cell death. 
Discovering new drugs and understanding their mechanisms of action may lead to 
more effective administration of these agents with other more established therapeutics in 
the treatment of cancer. To this end, better understanding the mechanism of PCD and 
identifying novel forms of cell death like BCD, would contribute in no small measure. 
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1.0. Introduction 
1.1. Historical Perspective: 
Early evidence of the existence of two morphologically distinct types of cell death 
came from the Ph.D. studies of Australian pathologist John Kerr, working under the 
supervision of Sir Roy Cameron, at the University College Hospital Medical School in 
London (Allen, 1995; Kerr, 1965; Kerr, 1995). Kerr ligated portal vein branches to the 
left and median lobe of the rat liver (Kerr, 1965). These lobes shrank to one sixth of their 
original weight in 8 days, and the other lobes simultaneously underwent hyperplasia, 
while the total weight of the liver remained approximately constant. In the atrophying 
lobes, patches of confluent necrosis occurred around terminal hepatic venules, whereas 
periportal parenchyma, sustained by blood from the hepatic artery, survived. Individual 
hepatocytes outside the zone of necrosis, in the absence of inflammation gave rise to 
small round cytoplasmic masses, some containing pyknotic chromatin, a manifestation of 
cell death distinctly different from necrosis, which Kerr named shrinkage necrosis. 
Histochemistry for acid phosphatase activity showed that although lysosomes in 
peri ventricular necrotic cells ruptured with dispersal of enzyme product in the cytoplasm, 
lysosomes in the small round cytoplasmic masses stained discretely, indicating that the 
lysosomes were still intact. "Shrinkage Necrosis" of hepatocytes also occurred in the 
normal liver. Ti;lj~ w.a.s a form of cell death morphologically distinct from necrosis. This 
1,: '.1,1 
cell death mechanism had features suggesting an intrinsically controlled active process 
that occurred under both physiological and pathological circumstances, was important in 
normal embryonic morphogenesis, and was also of great kinetic significance in tissues 
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and tumors (Kerr et al., 1972). Kerr, Wyllie and Currie in 1972, recognized that necrosis 
was an inappropriate teirn to describe active cell death occurring under physiological 
conditions, and proposed the term apoptosis for this process. This emphasized its role 
opposite to that of mitosis in regulating tissue size (Kerr et al., 1972). The word apoptosis 
was suggested by James Cormack, professor of classical Greek at the University of 
Aberdeen, and meant "falling off'' or "dropping ofP' (Kerr et al., 1972). It had been used 
by Homer to describe the dropping off ofleaves from trees in autumn (Wyllie, 1994 ). 
1.2. The Concept Of Cell Death: 
Knowledge in the field of cell death has greatly increased in the past 20 years. In the 
course ofthis rapid advance, new concepts, such as apoptosis, appeared on the scene, and 
ancient terms such as necrosis came to be used in a new context, leading to much 
confusion. A recent review saw fit to conclude that "there is no field of basic cell biology 
and cell pathology that is more confusing and more unintelligible than is the area of 
apoptosis versus necrosis" (Kerr et al. 1972). The complexity in defining the mode of cell 
death and in classification of different death mechanisms was recently reviewed by 
Majno and Joris (Majno and Joris, 1995). These authors convincingly argue that cell 
death and necrosis are two distinct events. Cell death according to these authors, is a 
process that leads to the point of no return; subsequent events are the postmortem 
changes, which these authors define as necrotic changes. In the case of induction of liver 
cell death by ischemia, for example, the irreversible point is at approximately 150 min 
after onset of oxygen deprivation (Majno and Joris, 1995). At that time, however, no 
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significant morphological changes can be seen, while the necrotic changes become 
visible only after 12 hours. Thus, the cells die, long before any morphological changes 
typical of necrosis can be detected. The term cell death "by necrosis", which implies that 
necrotic changes accompany, appears to be contradictory and confusing. Additionally 
confusing is the traditional use of the term "necrosis" in pathology to describe gross 
tissue changes, visible by eye and occurring after cell death, i.e., attributed to postmortem 
cell changes (Majno and Joris, 1995). 
The term "accidental cell death" to define the mode of cell death which is now 
generally denoted as cell necrosis, and "oncosis" to portray the early stages of accidental 
cell death was proposed by Majno and Joris. The term oncosis has been used by 
pathologists to describe cell death associated with cell swelling ( oncos = swelling) which 
occurrs during slow ischemia, e.g., as in the case of death of osteocytes entombed in bone 
tissue during osteogenesis. The features of oncosis are identical to those seen in the early 
phase of accidental cell death in a variety of cell systems. Within the framework of 
classification of cell death proposed by Majno and Joris, the necrotic step follows either 
oncosis or apoptosis and thus can be denoted either as "oncotic necrosis" or "apoptotic 
necrosis", respectively (Majno and Joris, 1995). The common features of such late 
necrotic cells, regardless of whether they were dying by apoptosis or oncosis, are loss of 
plasma membrane transport (ability to exclude charged ions such as propidium iodide or 
trypan blue), autolytic processes, dissolution of the remnants of chromatin (karyolysis), 
etc (Majno and Joris, 1995). 
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1.3. Cell Necrobiology: 
The interest in cell death spans a wide range of diverse disciplines, including cell and 
molecular biology, oncology, immunology, embryology, endocrinology, hematology, 
neurology, plant biology, and biotechnology. Of particular interest are molecular 
mechanisms which predispose the cell to respond to an environmental or intrinsic signal 
by death and/or regulate the initial steps leading to the irreversible commitment to death. 
It is suggested that, since this subject is so wide and involves so many disciplines, a new 
field of biology and medicine is called for and the tenn "cell necrobiology" has been 
proposed to define this field (Darzynkiewicz et al., 1997). The term necrobiology refers 
to the life processes associated with morphological, biochemical and molecular changes 
which predispose, precede and accompany cell death, being derived from necros (death) 
and bios (life), reflecting their inevitably intertwined relationship. Cell necrobiology, 
thus, represents a wide area of research which includes different modes of cell death, the 
biological processes which predispose, precede and accompany cell death, as well as the 
consequences and tissue response to cell death. On the other hand the term "cell 
necrology" may be reserved to define specifically the field of studies dealing with the 
post-mortem changes, occurring in the cell which has passed the point of "no return" in 
its journey towards death (Darzynkiewicz et al., 1997). 
1.4. Multidisciplinary Interest In Cell Necrobiology: 
A multistep complex mechanism regulates the cell's propensity to respond to various 
stimuli by apoptosis (Oltvai and Korsmeyer, 1994; Rowan and Fisher, 1997; Nagata, 
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1997; Goldstein, 1997; Kumar, 1997). The regulatory system involves the presence of at 
least two distinct stages, one controlled by the Bcl-2 family of proteins (Nagata, 1997; 
Goldstein, 1997; Kumar, 1997; Hockenberry, 1995; Lomo et al., 1996; Reed, 1994) and 
another by cysteine (Femandez-Alnembri et al., 1995; Lazebnic et al., 1994; Nicholson, 
et al., 1995; Alnembri et al., 1996) and also possibly by serine (Bruno et al., 1992; 
Gorczyca et al., 1992, Hara et al., 1996; Weaver, et al., 1993) proteases. Among the 
proteins controlling the first stage, Bcl-2, Mcl-1, and Bel-xi promote cell survival while 
Bax, Bcl-xs, Bak and, Bad enhance the cell's propensity to undergo apoptosis. All 
members of the Bcl-2 family contain well conserved domains that allow for the formation 
of homo- and hetero-dimers between members. The cysteine (ICE) proteases, recently 
renamed caspases (Alnemri et al., 1996), consist of at least 11 homologous enzymes with 
somewhat different substrate specificities. Caspases interact with the receptors 
transferring apoptotic signals through the plasma membrane such as Fas or TNF receptor 
1 (TNFRI) via adaptor molecules such as FADD/MORT 1, through interactions between 
the well conserved death domains of these proteins (Nagata, 1997; Chinnaiyan, 1996; 
Kiston et al., 1996). There is a growing body of evidence that the Bcl-2 family of proteins 
act upstream of caspases (Nagata, 1997). Although not being direct modulators of 
caspases, the Bcl-2 proteins appear to activate these proteases perhaps by engaging their 
activator (Nagata, 1997; Krippner et al., 1996). 
The wide interest in apoptosis stems from the realization that it is an active and, as 
mentioned above, highly regulated mode of cell death. In addition to the Bcl-2 family of 
proteins and caspases, a plethora of other molecules, which either promote or prevent 
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apoptosis, have been discovered to interact with the regulatory machinery of apoptosis. 
Some are the products of oncogenes or tumor supressor genes, e.g., such as c-myc or wild 
type p53 (Evan et al., 1992; Clarke et al., 1993; Pavlovich et al., 1997). Others are viral 
proteins such as BHRF1, a product of the Epstein Barr virus, which is homologous to 
Bcl-2, or cnnA, a product of cowpox virus, an inhibitor of caspases (Ray et al., 1992; 
Williams and Smith, 1993). These virally encoded proteins promote their intracellular 
propagation by postponing apoptosis. Given such a wide range of regulatory steps and 
molecules, there are many possibilities for interaction with the components involved in 
the regulation of apoptosis and thereby to modulate the cell's propensity to die. It is not 
surprising, therefore, that apoptotic mechanisms are the focus of interest of many 
researchers in the field of oncology. 
Numerous strategies designed to utilize these mechanisms to modulate the sensitivity 
of the tumor and/or normal cells to anti-tumor agents, and, as a result, to increase the 
efficiency of treatment and/or to lower drug toxicity to the patient, have been considered 
(Darzynkiewicz, 1995; Dive and Hickmann, 1991; Fisher, 1994; Hannun, .1997; 
Hickmann, 1992, Kerr et al. 1994). Another finding promoting interest in apoptosis was 
the identification of the gene protecting cells from apoptosis (Bcl-2) as an oncogene 
(Tsujimoto et al., 1985). This finding revealed that not only a defect in the cell cycle 
results in uncontrolled cell proliferation but also the loss of the cell ' s ability to die on 
schedule may be a cause of cancer. More recently it has become apparent that tumor 
progression and increased malignancy are also associated with the change in the 
propensity of tumor cells to undergo spontaneous apoptosis (Hercbergs and Ieith, 1993; 
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Isaacs, 1993; Laidlaw and Potten 1992). The rate of spontaneous apoptosis in tumors as 
well as apoptosis induced by chemotherapy, therefore, have become areas of intense 
interest in oncology. In the latter case, it has been recently demonstrated that the ability 
of antitumor agents to induce apoptosis can be analyzed in the course oftherapy, thereby 
providing the possibility of rapid assessment oftheir efficiency (Gorczyca et al., 1993; Li 
et al., 1994; Seiter et al., 1995; Halicka et al., 1997). 
Another discipline where wide interest is focused on apoptosis, is immunology. 
Apoptosis plays a fundamental role in the clonal selection ofT cells and is implicated in 
many other normal and pathological reactions (Cohen, 1993; Linette and Korsmeyer, 
1994). Of particular interest is the mechanism of cell killing by NK lymphocytes, which 
is based in the use ofthe apoptotic effector machinery (Young et al., 1986). Furthermore, 
since progression of AIDS appears to be correlated with the rate at which T cells die by 
apoptosis, attempts are being made to monitor apoptosis of these cells and evaluate such 
measurements as markers of disease progression and prognosis (Echaniz et al., 1995; 
Meyaard et al., 1992). 
Male fertility is a field where apoptosis appears to be of particular interest. It has 
been observed that DNA in chromatin of abnormal infertile sperm cells, in contrast to 
normal sperm cells, is excessively sensitive to heat or acid-induced denaturation 
(Evanson et al., 1980). The DNA in these cells also has numerous strand breaks 
(Gorczyca et al., 1993). Furthermore, the DNA in situ in sperm is more accessible to 
actinomycin D (Gledhill et al., 1971). These three features are also typical of DNA in the 
chromatin of apoptotic somatic cells (Hotz et al., 1992; Hotz et al., 1994). Therefore, it 
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was proposed that an apoptosis-like mechanism may be triggered to eliminate cells 
bearing various types of DNA damage, including mutations, even at late stages of 
spermatogenesis (Laidlaw and Potten, 1992). However, because such highly 
differentiated cells may have already lost many effectors of apoptosis, the process may be 
incomplete, resulting only in activation of an endonuclease which causes extensive DNA 
degradation, effectively eliminating such cells from the reproductive pool but not leading 
to their physical disintergration. Such spermatozoa may still have mitochondrial activity, 
normal motility, and, in some cases, even normal morphology (Evenson et al., 1980). 
Analysis of in situ DNA denaturability in sperm cells, assayed by flow cytometry, has 
become increasingly popular as a marker of infertility and in toxicology studies to assay 
the genotoxic effects of environmental agents (Evenson et al., 1993; Sailer et al., 1995). 
1.5. Apoptosis (cell death by suicide): 
There are three forms by which cells may commit suicide: by lysosomes, by free 
radicals, and by a genetic mechanism (apoptosis) (Majno and Joris, 1995). Thus, of these 
three, apoptosis stands out as a form of intentional suicide based on a genetic mechanism 
(Majno and Joris, 1995). Listed below are the salient features of apoptosis: 
(1). Apoptosis is a form of cell death characterized by morphological as well as 
biochemical criteria and can be considered as a counterpart of mitosis (Majno and Joris, 
1995). 
(2). Morphologically the cell sluinks and becomes denser, as implied in the original name 
"shrinkage necrosis" (Kerr, 1971). The chromatin becomes pyknotic and packed into 
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smooth masses applied against the nuclear membrane (margination of chromatin), 
creating curved profiles that have inspired descriptive terms for over a century, such as 
half-moon-, horse-shoe-, sickle-, lancet and ship-like (navicular) (Schmaus and Albrecht, 
1894; Rechsteiner, 1988). The nucleus may also break up (karyorhexis), and the cell 
emits processes (the budding phenomenon) that often contain pyknotic nuclear 
fragments. These processes tend to break off and become apoptotic bodies, which may be 
phagocytized by macrophages or neighbouring cells or remain free; however, the cell 
may also shrink into a dense, rounded mass, as a single apoptotic body (Kerr, 1971). 
(3). There is little or no swelling of mitochondria or other organelles (Majno and Joris, 
1995). 
( 4). Biochemically, the DNA is broken down into segments that are multiples of 
approximately 185 bp, due to specific cleavage between nucleosomes (Oberhammer et 
al., 1993). 
(5). The process is under genetic control (Kerr et al, 1994; Wyllie, 1994) and can be 
initiated by an internal clock, or by extracellular agents such as hormones, cytokines, 
killer cells, and a variety of chemical, physical and viral agents. 
(6). Apoptosis can run its course very quickly, even in minutes (Majno and Joris, 1995). 
For this reason apoptosis is remarkably unobtrusive in tissue sections (Weedon et al., 
1979). In routine sections the best cytological marker of apoptosis is karyorhexis, 
especially in an isolated cell. Fortunately, a recent technical advance makes the 
identification of apoptosis a matter of simple histochemistry, a method that takes 
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advantage of the fact that the DNA breaking points (nicks) expose molecular endings that 
are chemically specific (Gavrieli et al., 1992). 
(7). The rapidly developing tale of apoptosis warns us that generalizations are dangerous 
because, first, cell suicide does not always take the form of apoptosis; second, cell 
murder by cytotoxic lymphocytes leads to apoptosis; third, there seem to be several 
varieties of apoptosis (Martin, 1993) and fourth, different cell types may follow different 
rules (Vir chow, 1971 ). 
10 
Table 1: Changes in cell morphology and molecular events during apoptosis. 
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(A) Morphological Changes 
• Cell Shrinkage 
• Cell shape change 
• Nuclear chromatin condensation 
Loss of visually recognizable nuclear structure (framework) 
DNA hyperchromicity 
• Dissolution of nuclear envelope 
• Nuclear fragmentation 
• Condensation of cytoplasm 
• Loss of cell surface structures (pseudopodia, microvilli) 
• Formation of apoptotic bodies ("budding", "blebbing") 
• Detachment of cells in cultures 
• Phagocytosis of the apoptotic cell remains 
(B) Biochemical and Molecular Events of Apoptosis 
• Increased ratio of apoptosis promoters vs inhibitors of the Bcl-2 family 
• Mitochondrial changes 
Decrease in the transmembrane potential 
Leakage of cytochrome C 
Oxidative stress (formation ofROI) 
• Intracellular Ca++ rise 
• Loss of asymmetry in plasma membrane phospholipids 
• Activation of serine protease( s) 
• Cascade-activation of caspases 
Proteolysis of the "death substrates" 
• Degradation ofF actin and proteins other than "death substrates" 
• Loss ofDNA stability to denaturation 
• Endonucleolytic DNA degradation 
50-300 kb fragments 
Cleavage of intemucleosomal DNA 
• Activation oftransglutaminase 
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1.6. Accidental Cell Death: 
For cell death not by apoptosis the most satisfactory term is accidental cell death. 
Necrosis is commonly 'used but it is not appropriate, because it does not indicate a form 
of cell death but refers to changes secondary to cell death by any mechanism, including 
apoptosis (Majno and Joris, 1995). Abundant data are available on one form of accidental 
cell death, namely ischemic cell death, which can be considered an entity of its own, 
caused by failure of the ionic pumps of the plasma membrane. Because ischemic cell 
death (in known models) is accompanied by swelling, the name oncosis was proposed for 
this condition (Majno and Joris, 1995). The term oncosis (derived from oncos, meaning 
swelling) was proposed in 1910 by von Recklinghausen precisely to mean cell death with 
swelling. Oncosis leads to necrosis with karyolysis and stands in contrast to apoptosis, 
which leads to necrosis with karyohexis and cell shrinkage (Majno and Joris, 1995). 
Salient features of oncosis as defined by Majno and Joris are listed below: 
(1). Oncosis is a form of cell death accompanied by cellular swelling, blebbing, and 
increased membrane permeability. 
(2). It's mechanism is based on failure of ionic pumps on the plasma membrane. 
(3). It is caused, typically, by ischemia and possibly by toxic agents that interfere with 
ATP generation or increase the permeability of the plasma membrane. 
( 4). It evolves within 24 hours to typical necrosis. 
(5). It is usually accompanied by karyolysis. 
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( 6). It can be diagnosed by tests of permeability on whole cells, either in suspension (by 
dye exclusion tests) or by electron microscopy (using a colloidal marker) (Hoffstein et 
al., 1975). 
(7). The DNA breaks down in a nonspecific fashion (Wyllie et al., 1984). 
(8). The cellular changes (increased permeability of the plasma membrane, cell swelling, 
organelle swelling and vacuolizatio~ and simultaneous protein denaturation and 
hydrolysis) can only be hinted at by ordinary histological techniques. 
Many experiments have shown that blebbing, described above, begins during the 
early stages of ischemic damage and is initially reversible (van Gorp et al., 1999). Large 
blebs may burst, and it has been suggested that this may be the final blow to a dying cell 
(Majno and Joris, 1995). 
Thus, while apoptosis is characterized by the active participation of the affected 
cell in its own destruction, even to the point of triggering (in some cell systems) the de 
novo synthesis of cell death effector molecules, accidental cell death, generally results 
from the gross injury to the cell induced by an overdose of cytotoxic agents and is a 
passive, catabolic and degenerative process. An early event of accidental cell death is 
mitochondrial swelling, which is followed by the rupture of the plasma membrane and 
release of cytoplasmic constituents, including proteolytic enzymes, outside of the cell 
(Majno and Joris, '1995; Wyllie, 1992). Nuclear chromatin shows patchy areas of 
condensation and the nucleus undergoes slow dissolution (karyolysis). Necrosis triggers 
an inflammatory reaction in the tissue and often result in scar formation. DNA 
degradation is much less extensive during necrosis compared to apoptosis and the 
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products of degradation are heterogenous in size, forming a smear rather than discrete 
bands on electrophoretic gels (Gorczyca et al., 1992). 
Cell death does not always manifest classical features of either apoptosis or 
necrosis. Many examples of cell death have been described in which the pattern of 
morphological and/or biochemical changes resemble neither typical apoptosis nor 
necrosis but often contain features of both (Cohen et al., 1992; Collins et al., 1992; 
Ormerod et al., 1994; Zakeri et al. 1993; Zamai et al., 1996; Akagi et al., 1995; 
Catchpoole and Stewart, 1993; Fukuda et al., 1993). In some cases, the integrity of the 
plasma membrane was preserved but DNA degradation was random, without evidence of 
internucleosomal cleavage. In other situations, DNA degradation was typical of apoptosis 
but nuclear fragmentation and other features of apoptosis were not apparent. Generally, 
while most hematopoietic lineage cell types are "primed" to undergo apoptosis and their 
death has typical features of apoptosis, the death of epithelial type cells or fibroblasts 
provide a more complex pattern that is sometimes difficult to classify. Furthermore, some 
drugs, which cause apoptosis, may additionally confuse the pattern of cell death due to 
drug-induced secondary effects on the cell. When apoptosis is triggered by drugs 
effecting cell structure and function, or by drugs effecting one or more pathways of the 
apoptotic cascade, particular features of apoptosis may not be apparent. Induction of 
apoptosis in the presence of inhibitors of proteases, for example, can lead to cell death 
without evidence of nuclear fragmentation or a decrease in the stability of DNA to 
denaturation (Hara et al., 1996). Likewise, prolonged cell arrest in the cell cycle induced 
by some drugs can result in growth imbalance that may dramatically alter cell 
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biochemistry and morphology. The apoptotic features of such cells are much different 
compared to untreated cells (Gong et al., 1995). 
1. 7. Early And Delayed Apoptosis. Relationship to the cell cycle: 
It has been observed in numerous studies that exposure of lymphocytes or 
hematological tumor cell lines to pharmacological concentrations of antitumor drugs or 
radiation induces their rapid apoptosis, which can be seen as early as 2-4 h after the onset 
of treatment (Gorczyca et al., 1992; Gorczyca et al., 1993). Likewise, apoptosis of 
lymphocytes induced by their activation, corticosteroids, or via engagement of the Fas 
receptor, by Fas ligand, or by TNF, also is rapid. In all these cases, the pattern of 
apoptosis is quite typical and the cells exhibit nearly all the characteristic apoptotic 
features, as listed in Table 1. During this early apoptosis the cells generally die in the 
same cell cycle, prior to mitosis. A term "homo-cycle" apoptosis has been proposed to 
define apoptosis which occurs in the same cycle in which the cells were initially exposed 
to the apoptosis triggering agent, prior to, or during mitosis. Often the cells die in the 
same phase of the cycle, without progressing to the next one. To define such death, the 
term "homo-phase apoptosis" applies (Halicka et al., 1997). An example of such 
apoptosis is rapid death of S phase cells during treatment of exponentially growing cell 
populations with DNA topoisomerase inhibitors (Gorczyca et al., 1993; Del Bino et al., 
1991 ). In contrast to "homo-cycle apoptosis", the term "postmitotic apoptosis" has been 
proposed to describe apoptosis which occurs in a cell cycle stage subsequent to the one in 
which the initial damage to the cell was induced (Halicka et al., 1997). 
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This subdivision is pertinent in relation to the possible differences in mechanisms 
triggering apoptosis. During homo-phase apoptosis, which for example, occurs in S 
phase, the cells do not traverse G 1 or G2 check points. Therefore the product of the tumor 
suppressor gene p53, which controls these check points, may not play a significant 
sensitizing role, as it otherwise does in cells that traverse these check points. Anti-tumor 
strategies involving p53 and the checkpoints, therefore, may be different for drugs 
inducing homo-phase vs post mitotic apoptosis (Halicka et al., 1997). 
While early apoptosis occurs between 30 minutes and 8 hours after induction of damage 
in the cell, apoptosis may also occur after a considerable delay. For example, exposure of 
cells to anti-tumor drugs at low concentrations or when transient (pulse) treatment with 
drugs or radiation is followed by growth in drug-free-media, the initial results may be 
perturbation of cell cycle progression (cytostatic effect). Subsequently, such cells may 
either resume cell cycle progression and even be capable of reproduction after removal of 
the drug from the medium, or they may die with a delay. Cell death in such a situation is 
often due not only to the primary damage but may also result from the accumulation of 
secondary changes that occurred during the cytostatic phase. One such change is growing 
imbalance. During inhibition of DNA replication, RNA and protein synthesis continue, 
but many genes which were initially damaged by the drug may become transcriptionally 
inactive. The cells die if products of these genes are essential for their survival. Less is 
known about whether altered ratios of overall RNA/DNA or protein/DNA, gross features 
characteristic of cell growth imbalance, may themselves contribute to cell death 
(Gorczyca et al., 1993; Del Bino et al., 1991). 
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Delayed apoptosis is also observed in the case of certain cell types, in particular 
cells of epithelial cell origin even following exposure to cytotoxic drug concentrations or 
radiation (Chang and Little, 1991; Shinohara and Nakano, 1993). It is possible that the 
cells, which do not undergo early apoptosis, lack the required effectors of apoptosis. The 
apoptosis-triggering event, in these cells, induces transcription of genes encoding the 
effector(s), which explains a delay in the execution of apoptosis. Inhibition of protein 
synthesis by cycloheximide, in such cases, generally protects the cells from apoptosis 
(however, as discussed later, cycloheximide may not inhibit apoptosis when post-
translational modification of proteins rather than its de novo synthesis may be involved). 
For example T cell leukemic MOLT-4 cells do not undergo early apoptosis (Del Bino et 
al., 1990), most likely because they lack the action of the apoptosis-associated 
endonuclease, which is induced with a delay (Matsubara et al., 1994). 
Interestingly, the phase of the cell cycle in which the cells undergo apoptosis in 
response to a particular drug is often different in the case of early vs delayed apoptosis. 
Transient exposure of cells to a drug which, for example, induces early apoptosis in S 
(e.g., teniposide) or in G2 M phase (taxol), followed by cell growth in drug-free medium, 
leads to cell death not only inS or G2 M but often in G1 phase (Halicka et al. , 1997). 
1.8. Incidence of aooptosis: 
Apoptosis has a significant role in physiological and developmental processes, but it 
also accounts for cell death occurring under a variety of pathological circumstances (Kerr 
and Harmon, 1991; Kerr et al., 1987; Kerr et al., 1994; Walker et al. , 1988; Wyllie et al. , 
1980). An abbreviated report of its occurrence follows. 
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1.8.1. Normal Development: 
Many parallels can be drawn between developmental processes in lower species 
and mammals. Study of the finely regulated developmental cell death that occurs in the 
nematode Caenorhabditis elegans has provided insights into the genetic control of 
apoptosis in higher animals (Yuan and Horvitz, 1990). For example, ICE and bcl-2 
protein are the homologues of the protein products of the C. elegans death modulating 
genes, ced-3 and ced-9. 
During metamorphosis, regression of larval organs in lower vertebrates, for 
example, loss of tail as a tadpole matures into a frog, occurs by morphologically typical 
apoptosis (Kerr et al., 1974). In vertebrates apoptosis has been implicated in the 
development of most body systems (Gluckmann, 1951). 
In 1966, Saunders showed that the interdigital tissue of amniota embryos 
underwent extensive but controlled cell death, allowing digits to emerge from the early 
foot plate (Saunders, 1996). Morphological studies of the regressing tissue showed 
apoptosis, correlating with the intemucleosomal DNA fragmentation found on DNA gel 
electrophoresis (Garcia-Martinez et al. , 1993; Kerr et al., 1987). During fusion of the 
palatine shelves, redundant epithelium undergoes apoptosis as fusion progresses 
(Farbman, 1968; Kerr et al., 1987). 
Cell death during the development of the vertebrate nervous system has been 
studied extensively. It takes the form of apoptosis and involves a range of cell types, 
including astrocytes, oligodendrocytes (Barres et al., 1992), and neurons. Up to 50% of 
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neurones die soon after forming synaptic connections with their target cells: cell death is 
thought to reflect failure of neurones to receive specific survival factors from the target 
cells (Raffet al. 1993). 
During intrauterine life, epithelial cells in the mammalian intestinal mucosa undergo 
apoptosis, allowing widening of the lumen and the formation of villi (Harmon et al. , 
1984). In the normal developing rat kidney, metanephric mesenchymal cells are 
programmed for apoptosis, dying if they fail to receive survival signals from ureteric bud 
cells (Koseki et al., 1982). Invasion ofthe mesenchyme by the ureteric bud, an outgrowth 
of the wolffian duct, blocks apoptosis, and the mesenchyme converts to epithelium and 
differentiates. 
Apoptosis plays a key role in both the development and maintenance of the 
immune system (Williams, 1994). In the developing thymus, engagement of the T-cell 
receptor on immature T cells by self-antigen induces their death by apoptosis, self- . 
reactive T -cells thus being eliminated. Induction of tolerance in B cells probably also 
involves apoptosis and a similar process deletes autoreactive B cells (Murphy et al. ·1990; 
Smith et al., 1989). 
1.8.2. Atypical Apoptosis During Terminal Cell Differentiation: 
In some tissues, cells undergoing terminal differentiation exhibit some but not all 
features of apoptosis. For example, normoblast nuclei undergo condensation in 
association with DNA cleavage to regularly sized fragments (Williamson, 1970). After 
displacement to one pole of the cell, the nucleated portion is recognized and 
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phagocytosed by macrophages, leaving behind an intact erythrocyte (Skutelsky and 
Danon, 1972). In the developing chicken lens, primary lens fiber cell nuclei undergo 
pyknosis and disappear after cleavage of DNA to form nucleosomal fragments: so by 
birth, the center ofthe lens comprises nonnucleated tissue (Appleby and Modak, 1977). 
A specialized form of apoptosis also occurs in the skin as keratinocytes in the 
granular layer undergo terminal differentiation to form squames. Here, cells with classic 
apoptotic nuclear morphology are observed, and cleavage of their DNA to form 
nucleosomal-sized fragments can be demonstrated Budding and cellular fragmentation 
associated with normal apoptosis do not occur. The cell forms a flattened anucleate 
keratinocyte on the skin surface (McCall and Cohen, 1991). 
1.8.3. Normal Cell Turnover In Adult Tissues: 
Spontaneous apoptotic deletion of cells ts a consistent feature of slowly and 
rapidly proliferating mammalian cell populations. In tissues that comprise predominantly 
postmitotic cells, such as the brain and the heart, apoptosis is not normally identified 
(Walker et al., 1988). 
In slowly proliferating tissues, such as liver, prostate, pancreas and parotid gland, 
small numbers of apoptotic bodies are found in the normal tissue (Kerr, 1965; Kerr and 
Searle, 1973; Walker, 1987; Walker and Gobe, 1987). In the liver, these are almost 
always found in zone 3, next to the tenninal hepatic venule (Benedetti et al. , 1988). In the 
adult rat adrenal gland, where maintenance of the inner two thirds of the adrenal cortex is 
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finely regulated by serum ACTH levels, calculations suggest that over time the rate of 
apoptotic cell loss equals that of cell gain through mitosis (Wyllie et al., 1980). 
In rapidly proliferating tissues, such as gastrointestinal epithelium, there are well-
defined zones of both proliferation and apoptosis (Hall et al., 1994). In the small 
intestine, apoptotic cells are seen most frequently toward the tips of villi, although 
occasional apoptotic bodies are also identified close to the proliferative compartment 
within the intestinal crypts. Apoptotic bodies within the epithelium, and less frequently in 
the lamina propria, are seen also in the colon toward the top of crypts. Hall et al. have 
shown apoptosis with subsequent macrophage uptake of apoptotic bodies to be 
numerically more significant than luminal shedding, the latter traditionally regarded as 
the predominant mechanism of epithelial cell loss (Hall et al:, 1994 ). . 
In lymph nodes, there is a high death rate among germinal center centrocytes, as they are 
selected for their ability to bind antigen (MacLennan, 1994). Those not selected, undergo 
apoptosis and become the tingible bodies seen in germinal center macrophages (Liu et al., 
1989; Searle et al., 1982). 
After releasing most of their cytoplasm as platelets, megakaryocyte remnants in 
the bone marrow die by apoptosis (Radley and Haller, 1983). Senescent neutrophils also 
undergo apoptosis, such cells being recognized and phagocytosed by macrophages, thus 
preventing release of their lysosomal enzymes as they die and augmentation of the 
inflammatory response (Savill, 1992). Varying erythropoietin levels regulate the extent of 
apoptosis of late erythroid progenitors, thereby controlling the size of the red blood cell 
pool (Koury, 1992; Koury and Bondurant, 1990). 
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1.8.4. Cyclic Cell Loss In Adult Tissues: 
The size of many cell populations is under the control of growth factors or 
hormones, with cell deletion occurring when circulating levels of relevant factors fall. 
The cell loss invariably occurs by apoptosis (Ferguson and Anderson, 1981). 
In the normal adult human breast, mitosis of duct and ductular epithelial cells is 
maximal at day 25 and apoptosis on day 28 (of a 28-day menstrual cycle) (Ferguson and 
Anderson, 1981 ). The apoptotic peak correlates with a sharp decrease in immuno-staining 
for bcl-2 protein in lobular epithelium (Sabourin et al., 1994). The apoptotic cells are 
phagocytosed by neighboring epithelial and myoepithelial cells and intraepithelial 
macrophages rather than being shed into glandular lumens (Ferguson and Anderson, 
1981 ). Human endometrium shows increased loss of glandular epithelial cells by 
apoptosis in the late secretory, premenstrual and menstrual phases (Hopewood and 
Levison, 1976). Apoptotic cells and bodies are seen in epithelial cells and macrophages 
within and beneath the epithelium and rarely within gland lumens. Uterine epithelial cells 
surrounding the blastocyst at the implantation sites of mice and rats also undergo 
apoptosis, bringing the blastocyst into close association with endometrial stroma (Parr et 
al., 1987). 
1.8.5. Involution of organ tissue: 
Involution of the neonatal rat adrenal cortex occurs synchronously with known 
decreases in circulating ACTH in the neonatal period (Wyllie et al., 1973). In the first 3 
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to 5 days after birth, large numbers of apoptotic bodies are found in the adrenal cortex; 
subsequently the number falls to low levels. The lactating breast after weaning undergoes 
rapid involution, presumably related to falls in circulating prolactin levels (Walker et al., 
1989). In the mouse, initial involution proceeds rapidly, with large numbers of apoptotic 
epithelial cells being shed into gland lumens. Subsequently, there is more gradual 
regression to the resting state, with apoptotic bodies derived from epithelial and 
myoepithelial cells mostly being phagocytosed by intraepithelial macrophages. Apoptosis 
of endothelial cells, resulting in regression of the capillary networks, accompanies the 
loss of glandular tissue. Internucleosomal DNA fragmentation characteristic of apoptosis 
accompanies involution (Strange et al., 1982). 
Greater than 90% of ovarian follicles present at birth undergo atresia (Hsueh et 
al., 1994). Using a 3'- end labelling technique, DNA fragmentation characteristic of 
apoptosis is identified in atretic follicles of both chicken and porcine ovaries (Tilly et al. , 
1991). In postovulatory follicles, granulosa cells undergo apoptosis, whereas, thecal cells 
are relatively spared (Hurwitz and Adashi, 1993). In the regressing corpus luteum of 
sheep, endothelial cell apoptosis results in blood vessel depletion (Azmi and O' Shea, 
1984). In other tissues, the stimulus to involution is unknown, but apoptosis remains the 
mechanism of cell loss. For example, spontaneous involution of hair follicles during 
catagen involves apoptosis of epithelial cells in the outer root sheath, with apoptotic 
bodies phagocytosed predominantly by adjacent epithelial cells (Weedon and Strutton, 
1981). The resorption oftissues around erupting teeth also involves apoptosis (Schellens 
et al., 1982). 
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1.8.6. Pathological Atrophy and Regression of Induced Hyperplasia: 
Pathological atrophy is also effected by apoptotic deletion of cells. Thus, falls in 
circulating levels of trophic hormones following castration induced atrophy of the rat 
prostate (Kerr and Searle, 1973). Exocrine gland atrophy after duct obstruction (Walker, 
1987; Walker and Gobe, 1987), renal atrophy in experimental hydronephrosis (Gobe and 
Axelsen, 1987), and atrophy ofthe liver and kidney caused by mild ischemia (Gobe et al., 
1990; Kerr, 1971) involve apoptosis. As in involution of the lactating breast and corpus 
luteurn, apoptosis of endothelial cells may accompany the tissue atrophy (Walker, 1987; 
Walker and Gobe, 1987). Regression of induced hyperplasia is also generally effected by 
apoptosis. For example, deletion of proliferated bile ductules after the relief of common 
bile duct obstruction (Bhathal and Gall, 1985) and regression of hepatocyte hyperplasia 
after cessation of administration of cyproterone acetate occur by apoptosis (Borsch et al. , 
1985). 
1.8.7. Cell Mediated Immunity: 
Cell death induced by cytotoxic T -cells, K-cells and natural killer cells takes the 
form of apoptosis (Berke, 1994; Walker et al., 1988). Such death is part of immune 
surveillance: transformed and virally infected cells, which are potentially dangerous to 
the host, are recognized and removed. Induction of apoptosis in target cells by 
specifically sensitized T -lymphocytes may involve activation of cytoplasmic proteases in 
the target cell by engagement of the Fas receptor (also known as Apo-1 or CD95) (Enari 
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et al., 1995) or injection of granzyme B, a serine protease, through perforin pores in the 
target cell membrane (Shresta et al., 1995; Smyth and Trapani, 1995). T-cell mediated 
apoptotic cell death is also involved in transplant rejection (Krams et al., 1995), graft 
versus host desease (Ferrara and Deeg, 1991 ), acute and chronic hepatitis (Patel and 
Gores, 1995), primary biliary cirrhosis (Nakanuma et al., 1983) and lichen planus (Paus 
et al., 1993). Viral infection may also cause apoptosis through direct viral cytotoxicity, 
induction of tumor necrosis factor (TNF), or by producing conflicting growth signals 
(Shen and Shenk, 1995). Inappropriate induction of CD4+ T -cell apoptosis by human 
immuno-deficiency virus (HIV) may be relevant to the pathogenesis of acquired 
immunodeficiency syndrome (AIDS) (Ameisen et al., 1994; Laurent-Crawford et al. , 
1991). 
1.8.8. Neoplasia, Cancer Therapeutic Agents, and Toxins: 
Although impaired induction of apoptosis as a result of abnormal p53 or bcl-2 
gene expression undoubtedly contributes to the development and progression of many 
tumors, the execution phase must remain intact, as some apoptosis is present in virtually 
every malignant tumor (Kerr et al., 1994; Searle et al., 1973; Wyllie, 1985), often 
significantly retarding tumor growth (Kerr and Searle, 1972). Mild ischemia (Moor, 
1987), infiltration by cytotoxic T-lyphocytes (Curson and Weedon, 1979), release of 
TNF-a by macrophages (Bellomo et al. , 1992; Wright et al. , 1992), and intrinsic 
activation of apoptosis, probably all contribute towards tumor regression. Radiotherapy, 
hyperthermia and chemotherapy promote tumor regression, at least partly through the 
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induction ofapoptosis (Allan and Harmon, 1986; Hickman, 1992; Kerr et al., 1987; Kerr 
et al., 1994; Searle et al., 1982; Searle et a!., 1975; Walker et al. , 1988), but tumors 
lacking functional p53 or expressing bcl-2 are often resistant to these agents (Lowe et al., 
1993 ) . Toxins may induce apoptosis in normal tissues (Walker, 1988), often in a dose 
dependent manner, with Jow doses inducing apoptosis and high doses inducing necrosis 
(Kerr, 1972). 
1.9. Medicinally Useful Herbs: 
Medicinally useful herbs have made a great contribution to medical practice today. 
Today about 75% of the worlds population still relies on plants, plant extracts and other 
tools of traditional medicine (Abelson, 1990). There are about 121 clinically useful 
prescription drugs worldwide that are derived from higher plants. About 74% of them 
came to the attention of the pharmaceutical houses because of their use in traditional 
medicine (Abelson, 1990). Among the drugs derived from plants are the anticancer 
agents vinblastine, vincristine and more recently the benzo-phenanthridine alkaloids. 
They provide some of our most valuable medications from plants (as listed below). The 
medical value of plants is due particularly to the chemicals which they contain but a few 
plants may help because of their physical properties. Herbs often contain several of these 
chemical groups, sometimes in the leaves, sometimes in the roots, or indeed in the whole 
plant. The main groups of chemicals involved in medical use are listed below (Jones, 
1996): 
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I) Alkaloids: these complex nitrogenous compounds provide a number of our most 
potent drugs including morphine, quinine, caffeine and the novel class of benzo-
phenanthridine alkaloids (sanguinarine, chelerythrine etc.). 
2) Glycosides: these sugars are linked with a special complex chemical, e.g. the cardiac 
glycosides present in the foxglove. They include the saponins which can foam with 
water as in soapwort. 
3) Essential oils: it is a misleading term. They are volatile fatty acids, often fragrant. 
Many have valuable antibacterial and antiparasitic actions. Some like peppermint 
have beneficial effects on the digestive organs. 
4) Tannins: they have an astringent effect and are particularly present in those plants 
which have long had a tradition for stopping bleeding such as self-heal or the 
carpenter's herb (prunella vulgaris). Its use may have been helped by sphagnum moss 
which, with its great absorptive powers, has been used to stem serious bleeding since 
prehistoric times. 
5) Mucilages: these are polysaccharides, chemically linked chains of sugars which tend 
to form a gel with water. They can be immensely helpful in certain respiratory 
diseases. 
6) Bitter principles: these are non-poisonous bitter substances, particularly present in 
gentians, artemesias and hops. These act as digestive stimulants and also gives 
characteristic flavours. 
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7) Miscellaneous: there are many other groups including some which have not yet been 
synthesized by chemists and represent a great potential for future medicinal and 
domestic benefit. 
1.9.1. AJkaJoids: 
An alkaloid is any of a class of nitrogen-containing natural products of plant 
origin that have an alkalilike, or basic, chemical nature. Some alkaloids are simple, 
monocyclic (one ring) amines, but many are very complex, polycyclic amines. Various 
family groupings are possible according to basic ring structure, such as pyridine or 
quinolone alkaloids. The term was coined in 1819 by the german pharmacist, 
K.F.W.Meissner (http://www.entheogen.com/fatfreddie/chernlalkaloid.html). Primitive 
tribes in various parts of the world have known for centuries that physiological effects 
can be obtained by eating or chewing the leaves, roots or bark of certain plants. By trial 
and error these tribes have found that some plant extracts cure diseases and others are 
deadly poisons. 
Today thousands of different physiologically active compounds extracted from 
the leaves, barks, roots, flowers, and fruit of plants have been identified by chemists. 
Most of these are water insoluble, but they can be extracted from plant material by an 
acidic solution. Because they react with acid, these naturally occurring substances (most 
of which contain nitrogen-amides or amines) are called alkaloids, meaning "like a base" 
because bases react with acids. 
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An alkaloid is a physiologically active, nitrogen containing low molecular weight, 
base compound extracted from plant material (Pauli and Kutchan, 1998). A role in the 
chemical defence of the plant also emerges for alkaloids, causing this class of metabolites 
to be of both eco-chemical and pharmaceutical interest. Tetrahydrobenzylisoquinolone-
derived alkaloids constitute a large number of structurally diverse molecules that vary 
widely in physiological activity. Examples of this class of alkaloids that have been 
employed in modern medicine are the muscle relaxant bisbenzylisoquinoline alkaloid(+)-
tubacurarine used in abdominal surgery, the analgesic morphinan alkaloid morphine, the 
anti-tussive alkaloid codeine, the anti-microbial berberine alkaloid berberine and the anti-
microbial and anti-tumor quaternary benzo[c]phenanthridine alkaloid sanguinarine (Pauli 
and Kutchan, 1998). 
1.9.2. Sanguinarine: 
1.9.2.1. Structure-Activity relationship: 
The quaternary benzo[ c ]phenanthridine alkaloid sanguinarine occurs in several 
genera of the families Papaveraceae (e.g. Argemone, Bocconia, Chelidonium, 
Dicranostigma, Eschscholtzia, Glaucium, Hunnemannia, Hylomecon, Hypecoum, 
Macleaya, Meconopsis, Papaver, Platystemon, Romneya, Sanguinaria, Stylomecon and 
Stylophomm), Berberidaceae (Berberis and Mahonia), Fumariaceae (Corydalis, Dicentra 
and Fumaria) and less abundantly in Menispermaceae (Jateorhiza), Ranunculaceae 
(Thalictrum), Rutaceae (Zanthoxylum), Sapindaceae (Ptridophyllum) and other taxa 
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(Sehmeller et al., 1997). The benzophenanthridine nucleus consists of four fused coplanar 
aromatic rings, with various functional groups on the terminal rings (Bajaj, 1990). 
Sanguinarine ( 13-methyl[1,3]benzodioxolo[ 5,6-c ]-1.3-dioxolo[ 4,5-
i]phenanthridinium) is a commercial drug (see table 3 for structure) derived from the root 
of Sanguinaria canadensis (blood root), Chelidonium majus L. (Greater Celandine) and 
other poppy-fumaria species. Chelidonium majus L., a perennial of Papaveraceae, is a 
common plant growing on the euroasiatic continent. The orange coloured sap of the 
sterns and roots contains comparatively high concentrations of benzophenanthridine 
alkaloids, especially of the alkaloids chelidonine, chelerythrine, and sanguinarine and has 
a long history of being useful for the treatment of many diseases in european countries 
(Lenfeld et al., 1981). This plant is of great interest for its use also in chinese herbal 
medicine (Colombo and Bosisio, 1996). By standard methods more than twenty alkaloids 
have been detected in this plant. Three quaternary alkaloids from this plant, sanguinarine, 
chelerythrine and berberine, and a non quaternary one, chelidonine, have been separated 
by normal-phase chromatography (Han et al., 1991). 
From the stucture-activity relationships point of view, two main remarks can be 
drawn: 1) For all the compounds so far synthesized and studied, the iminium charge on 
the benzo[c]phenanthridine ring seem to be necessary for their biological action (Yves et 
a!., 1993; Arisava et al., 1984; Monroe, et al., 1987). 2) The reactivity of the iminium 
toward nucleophilic attack (Rodds chemistry of carbon compounds, 2nd ed., 1978) has 
been put forward to explain the antileukemia activity ofthese alkaloids (Ulrichova et al. , 
1991). The iminium bond of any quaternary benzo[c]phenanthridine alkaloid is highly 
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susceptible to nucleophilic attack. The addition of nucleophiles such as water, thioles, 
amines, and alcohols is the most common reaction of sanguinarine (Simanek, In: The 
Alkaloids, Vol 26, Academic Press; Dostal and Potacek, 1990). However, such a 
transformation leads to unstable products, which could be responsible for the acute 
toxicity reported (Arisawa et al., 1984; Rodds chemistry of carbon compounds, 2nd ed., 
1978). 
1.9.2.2. Pharmacological activities and applications: 
Many alkaloids of the benzo[c]phenanthridine family, including sanguinarine, 
display anti-tumor properties (Simeon et al., 1989). Apart from its anti-tumor properties, 
sanguinarine also shows antimicrobial activity against a wide variety of microorganisms 
including bacteria, fungi and protozoa. Sanguinarine acts as both a bacteriostatic agent 
and a bacteriacide to major gram positive and gram negative bacteria (Odebiyi and 
Sofowora, 1979; Vichkanova et al., 1969; Dzin and Sacransky, 1985). The pseudobases 
of sanguinarine as well as their alkanolamines and pseudocyanides are more potent than 
the iminium ions (Mitscher et al., 1978). These findings are assumed to be the result of 
higher pseudobase hydrophobicity, which causes an increase in bioavailability to the 
microorganism. The pseudobase form can be reverted to the iminium ion form inside the 
microorganism. Sanguinarine possesses good antifungal activity against candida albicans 
and the dermatophytes of trycophyton species Epidermophyton floccosum, Microsporum 
canis, and Aspergillus fumigatus (Hejmankova et al., 1984 ). Anti-inflammatory effects of 
sanguinarine have been demonstrated in carrageenan, kaolin, and formaldehyde induced 
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inflammation edema of the rat paw with activity similar to that of indomethacin when 
sanguinarine was administered orally at 5-10 mg/kg (Lenfeld et al., 1981 ). Following the 
oral administration of a 10 mglkg dose a prolonged anti-inflammatory effect of 
sanguinarine was observed (Lenfeld et al., 1981 ). Sanguinarine demonstrates a local 
anesthetic action more pronounced than that of procaine (Kelenney, 1960). Sanguinarine 
also interferes with adrenaline and acetylcholine pharmacology models in vitro 
(Ulrichova et al., 1983; Hakim, 1954). The medicinal applications of sanguinarine are 
derived from hundreds of years of experience in traditional medicine. Native American 
Indians used extracts containing sanguinarine as expectorant and escharotic agents (Becci 
et al., 1987). A quaternary benzo[c]phenanthridine extract in combination with ZnCh was 
used in North America around 1910 as a necrotic agent for accessible neoplasms (Lewis 
and Elvin-Lewis, 1977). Sanguinarine is an ingredient in many over the counter products 
including toothpaste, mouthwash, cough and cold remedies and homeopathic 
preparations (Frankos et al., 1990). · 
The biochemical activities of sanguinarine includes the inhibition of protein 
.kinase C (Janin et al., 1993; Gopalakrishna et al., 1995), NFkB (nuclear transcription 
factor) (Chaturvedi et al., 1997), Na+/K+ ATPase (Straub and Carver, 1975; Seifen et al., 
1979) and oftubulin assembly (Wolff and Knipling, 1993). By intercalation, sanguinarine 
forms a molecular complex with DNA, specifically binding to regions rich in guanosine-
cytosine (Sen and Maiti, 1994). 
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1.9.2.3. Pharmacokinetics: 
The pharmacokinetics of sanguinarine have been widely studied. Following a 
1 Omg/kg i. v. injection into rabbits, blood levels drop rapidly. The blood concentration of 
the alkaloid 15-20 min post injectionem was almost nondetectable, indicating fast 
elimination (Walterova et al., 1995). An in vitro dialysis of sanguinarine solutions against 
whole blood indicated that sanguinarine was not bound to the plasma, but preferentially 
adsorbed to red blood cells and this is in accord with in vivo evaluations (Dobbie and 
Iangham, 1961 ). Accumulated data also suggests that liver and GI tract are potential 
target tissues. In a study with humans 2.5-10% dispersions of sanguinarine in a 
degradable polymer gel were delivered subgingivally. Crevicular fluid showed detectable 
levels of sanguinarine for 12 days. However, no sanguinarine was detected in any blood 
sample during this period (Dunn et al., 1991). 
1.9.2.4. Toxicological evaluations and adverse effects: 
Acute toxicity of sanguinarine depends strongly on the mode of administration 
(Lenfeld et al., 1981; Kelenney, 1960,; Becci, et al., 1987; Frankos et al., 1990). A 
subcutaneous injection of sanguinarine results in an LDso for mice of 80 and 102 mg/kg, 
while an intravenous injection of sanguinarine results in an LD50 of 15.9 mg/kg. The 
LD50 in rats for i.v. administration was 29 mglkg with sanguinarine. An oral LDso of 
sanguinarine in rats ranges from 1525 to 1624 mg/kg depending upon the additive. The 
acute dermal LDso in rabbits was over 200 mglkg. Subchronic toxicity studies with 
sanguinarine in rats administered 1-15 mglkg/day in the diet for a period of 14 days and 
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in monkeys given 10-60 mglkg/day orally revealed no treatment related toxicity in any 
group apart from emesis and diarrhea, which was observed sporadically and only for 
limited time in monkeys at dosage levels > 30 mg/kg/day (Frankos et al., 1990). 
Intravenous administration of 5-15 mglkg sanguinarine to cats caused an increase in 
blood pressure, tonicity, intestinal peristalsis, and contraction of the spleen (Kelenney, 
1960). In reproductive and developmental toxicity, a fertility/reproduction study in rats 
has shown an increase in mortality at 100mglkg/day. Reduced pup weight was observed 
at high doses only. Cardiovascular toxicity has been tested. Intravenous injections of 
sanguinarine (0.5-4.0 mglkg) to guinea pigs produced a dose-related increase in the 
ventricular effective refractory periods (Whittle et al., 1980). 
Sanguinarine inhibits the hepatic drug-metabolizing enzyme system. Sanguinarine at 10 
mglkg i.p. prolonged pentobarbital sleep in rats (Dalvi and Peeples, 1981). 
The presence of sanguinarine in low concentrations in the seed oil from Argemone 
mexicana and Argemone ocroleuca has been suggested as the sole etiologic agent 
responsible for epidemic dropsy, associated with glaucoma (Das and Khanna, 1997). The 
bioavailability data on sanguinarine and the animal toxicity and safety data suggest these 
benzo[c]phenanthridine alkaloids to have a wide margin of safety when administered 
orally or topically (Frankos et al., 1990; Lord et al., 1989). 
1.10. Sanguinarine Induced PCD {apoptosis) and BCD In K562 Cells In Vitro: 
Previous studies in our laboratory have demonstrated that K562 cells, when 
exposed to sanguinarine for 2 hrs at concentrations of 1.5 ~g/ml and 12.5 ~g/ml, 
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displayed two different morphologies corresponding to two different modalities of cell 
death. At 1.5 !J.g/ml, cells displayed blebbing and shedding of membrane vesicles over 
the entire cell surface, consistent with the current criteria of apoptosis or programmed cell 
death (PCD). At concentrations of 12.5 J..Lg/ml, cells displayed the morphology of large 
blister formation (commonly a single blister and usually not more than two). This 
phenomenon was coined "blister cell death or BCD" (Liepins et al., 1996). Furthermore, 
these two morphologically distinct modalities of cell death were interphased by an 
apparently normal cell morphology at sanguinarine concentrations of 6.25 !J.g/ml, which 
was dubbed as "silent period" based on the fact that these cells displayed a morphology 
similar to control cells not exposed to the drug (Liepins et al., 1996). The phenomena of 
PCD and BCD induced by sanguinarine was termed "bimodal cell death (BMCD)". 
K562 erythroleukemia cells express low levels of endogenous Bcl-2 protein and 
fairly high levels of endogenous Bax protein (Kobayashi et al., 1998). This expression is 
found to be intriguing as these cells are rather resistant to apoptosis, which is not 
consistent with the cells' low levels of apoptosis-inhibiting Bcl-2 and high levels of 
apoptosis-facilitating Bax (Kobayashi et al., 1998). This cell line, originally established 
in the laboratory of Lozzio et al., are multipotential hematopoietic malignant cells that 
spontaneously differentiate into recognizable progenitors of the erythrocytic, granulocytic 
and monocytic series (Lozzio et al., 1981 ). 
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1.11. Aurin tricarboxylic acid (ATA): 
Aurin tricarboxylic acid is a heterogenous mixture of polymers (see table 3 for 
structure) that forms when salicylic acid is treated with formaldehyde, sulfuric acid and 
sodium nitrite (Gonzalez et al., 1979; Cushman et al., 1991a; Cushman et al. , 1991b). 
This triphenylmethane dye or AT A, is an inhibitor of nucleases in vitro and has been 
shown to inhibit the followin enzymes: DNAse I, RNAse A, S 1 nuclease, exonuclease 
III, and restriction endonucleases Sal I. Bam ill, Pst I and Sma I (Hallick et al. , 1977). 
ATA has also been reported to prevent apoptosis in nerve growth factor dependent 
sympathetic neurons and PC12 cells (Batistatau and Greene, 1991). As ATA was initially 
shown to inhibit template binding to Qf3 replicase (Blumenthal and Landers, 1973) and to 
prevent the binding of RNA to ribosomes (Webster and Zinder, 1969), it was postulated 
that this compound would inhibit the association of any nucleic acid binding protein with 
nucleic acid. The ATA molecule carries three carboxylic acid moieties that are negatively 
charged at physiological pH. It has been suggested that these groups facilitate extensive 
ionic binding of the molecule to positively charged groups on cellular proteins (Bina-
Stein and Tritton, 1976). Nucleases, however, appear to be more sensitive to inhibition by 
ATA than many other enzymes (Bina-Stein and Tritton, 1976). 
1.12. Objective Of Present Study: 
It is known that various factors maintain inhibition of apoptosis and when 
withdrawn result in induction of apoptosis. An example of this is interleukin-6 (IL6), 
which is a well known survival/growth factor for a murine B cell hybridoma, 7TD 1 (Liu 
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et al., 1994). After IL6 deprivation, the cells became growth arrested and demonstrated 
signs considered to be the hallmark of apoptosis (Liu et al., 1994). It is also known that 
the expression of Bcl-2 inhibits apoptosis induced by various factors (Reed, 1994). An 
example of this is the work undertaken with sanguinarine in our laboratory (Weerasinghe 
et al. , in preparation). It has been shown that the Bcl-2 gene product plays an anti 
apoptotic role in sanguinarine induced apoptosis. Chemicals that mimic the effects of 
these natural factors also inhibit the apoptotic process. This is exemplified by the 
inhibition of apoptosis by the endonuclease inhibitor ATA and by the protein synthesis 
inhibitor CHX (Liu, et al. , 1994; Yanagihara and Tsumuraya, 1992) 
The present study was designed to assess the underlying mechanisms and to 
characterize the PCD and BCD induced by sanguinarine in K562 cells. The initial 
objective was to discover chemical compounds with known biological effects that would 
inhibit the induction of PCD and/or BCD by sanguinarine. This was achieved by 
pretreatment of these cells with chemical compounds drawn from different groups, 
previously proven to be inhibitors of apoptosis. A list of such compounds, their 
respective drug actions and biological effects follows. 
Table 2: A list of chemical compounds that regulate apoptosis, with their respective drug 
actions and biological effects (as described in "The Merck Index- An Encyclopedia of 
Chemicals, Drugs, and Biologicals", 1999), used in the preliminary pretreatment 
screening test. 
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AGENT DRUG EFFECT BIO. EFFECTS 
Aurintricarboxy lie acid (Liu, metabolic inhibitor endonuclease inhibitor 
et al., 1994) 
Cycloheximide (Liu et al. , metabolic inhibitor protein synthesis inhibitor 
1994, Yanagihara and 
Tsumuraya, 1992) 
Actinomycin D (Atlante et al. , metabolic inhibitor disruption of replication and 
1998) transcription 
Cyclosporin A (Crabtree and metabolic inhibitor Immunosuppressant. 
Clipstone, 1994) 
Glutathione (Park et al., 2000; endogenous antioxidant maJor thiol compound of 
Yang et al., 2000) living plant or animal cell 
Butylated hydroxy toluene antioxidant Antioxidant for food I 
(Anderson et al., 1999) antimicrobial activity 
Dithiothreitol (Yu, et al., antioxidant Proteolytic agent 
2000; Liu et al., 1999) 
Mepacrine (Fabisiak, et al., Phospholipase A2 (PLA2) Anti helminthic I parasite I 
1998; Shin, et al., 1999; inhibitor protozoal 
Jaattela, et al., 1995) 
Verapamil (Ares, et al., 1997) CaZ+ channel blocker Anti-arrythmic and vaso-
dilating agent 
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Nifedipine (Ares, et al., 1997) Ca:l+ channel blocker Anti-arrythmic and vaso-
dilating agent 
N-Acetyl-L-cysteine (Ferrari Mucolytic agent and thiol- Inhibitor ofHIV replication 
etal., 1995) based antioxidant 
Pargyline (Malorni et al., MAO inhibitor endonuclease inhibitor 
1998; Tatton, et al., 1994) 
3-Aminobenzamide (Malomi Inhibitor of poly-(ADP-ribose) Anti-inflammatory agent 
et al., 1995) polymerase (P ARP) 
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Preliminary results ofthis screening test showed that only aurin tricarboxylic acid 
(ATA) was able to inhibit the morphology ofPCD (considered a universal criterion for 
the identification of apoptosis) and BCD. Pretreatment of cells with ATA was able to 
completely inhibit the morphology of sanguinarine induced apoptosis, while the 
morphology of BCD was inhibited by about 30-40%. These preliminary data from light 
microscopic analysis were confirmed with more detailed study using a host of standard 
methods: quantitative light microscopy; electron microscopy for a more detailed study of 
certain organelles; "TUNEL" (TdT mediated dUTP nick end labelling) assay for DNA 
nicking; annexin V assay (by fluorescence microscopy and flowcytometric analysis) for 
the "phosphatidyl serine" (PS) flip; 51Cr release assay for membrane permeability; trypan 
blue exclusion assay for cell viability; flowcytometry studies for DNA content; oxygen 
consumption studies for cellular activity and mitochondrial function. As with AT A, these 
studies were also conducted with cycloheximide (see table 3 for structure) pretreatment. 
This was done regardless of the fact that CHX pretreatment was unable to inhibit 
sanguinarine induced PCD and BCD at the preliminary screening. Below-mentioned are 
the 4 primary reasons for undertaking experiments with CHX pretreatment parallel to that 
of AT A. 
1). To confrrm the results ofthe preliminary screening, that CHX, in fact does not inhibit 
the PCD nor BCD of sanguinarine. 
2). To ascertain whether de novo protein synthesis was required for either modality of 
cell death as CHX was a proven inhibitor of apoptosis with compelling evidence of this 
in literature (Liu et al. ~ 1994; Y anagihara and Tsumuraya, 1992). 
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3). To unveil even a subtle inhibition of sanguinarine induced PCD and/or BCD, despite 
not showing any inhibition in the screening preliminary test. 
4). To have a protein synthesis inhibitor in CHX as a contrast to the endonuclease 
inhibitor ATA. 
Table 3: Chemical structures of sangumanne, aunn tricarboxylic acid and 
cycloheximide. 
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Name of Drug/ 
Chemical Compound 
Sanguinarine 
Aurin tri-
carboxylic acid 
Cycloheximide 
Structure 
OH 
-oocQ 
C=O=O A coo-
Vcoo· 
OH 
0 
0 
2.0. Materials and Methods 
2.1. Materials: 
The K562 erythroleukemia cell line was purchased from ATCC (Rockville, l\10, 
USA). The drugs sanguinarine-HCI, AT A and CHX were purchased from Sigma 
Chemicals Co. (St. Louis, MO). Sanguinarine-HCl was maintained as a dry powder at 
room temperature. It was dissolved in deionized water, at 1 mg/ml, and used as a stock 
solution. Sanguinarine was subsequently diluted with RP:MI 1640 in order to make a 
working solution of25 J.lg/ml. ATA and CHX were maintained as dry powder and were 
dissolved in RPMI just prior to use. 
Annexin-v-fluos staining kit for the detection and quantification of apoptosis and 
differentiation from necrosis at the single cell level was purchased from Boehringer 
Mannheim. The "TUNEL" assay was purchased from Sigma Chemical Co. (St. Louis, 
MO). Both kits were stored and handled according to manufacturer's instructions. 
2.2. Cell culture: 
The K562 erythroleukemia cells were routinely maintained as a cell suspension in 
RPMI-1640 medium supplemented with 10% fetal calf serum and 2 ml L-glutamine in a 
humidified atmosphere containing 5% C02 at 37> C. All experiments were performed on 
K562 cells during their exponential phase of growth. 
2.3. Chemical treatment: 
2.3.1. Treatment of cells with sanguinarine: 
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A working sanguinarine solution of 50 Jlg/ml was prepared from a stock solution 
of 1 mg/ml. Sanguinarine was serially diluted in RPMI + 10% FBS to give a 
concentration range of 25 J.!g/ml to 0.19 Jlg/ml (8 dilutions) in 96 well plates. Triplicate 
wells for each drug concentration was prepared and aliquots of 10,000 cells (ATA 
pretreated, CHX pretreated or chemically untreated) per well were added. These tissue 
culture plates were subsequently incubated at 37° C + 5.0% C02 for two hours. Cells thus 
prepared were used in all subsequent experiments. 
2.3.2. Pretreatment of cells with metabolic inhibitors: 
2.3.2.1. Pretreatment of cells with ATA: 
A preliminary screening procedure was conducted in order to single out the 
optimum concentration and incubation period of ATA pretreatment that induced 
maximum inhibition of sanguinarine induced PCD and BCD. The concentrations of ATA 
used for this screening procedure were 50, 100 and 200 J..1M solutions, which were 
dissolved in RP:MI + 10% FBS. The incubation periods for the pretreatment of cells with 
ATA were 2, 12,24 and 48 hrs. These putative ATA concentrations were selected on the 
basis of the preliminary screening test and as per recent literature, eg. Liu et al., 1994. 
Since maximum inhibition of the morphology of sanguinarine induced apoptosis and 
BCD was achieved with pretreatment of ATA at concentrations of 100 f.1M for 2 hrs, all 
subsequent experiments were carried out under these AT A pretreatment conditions. 
Thereafter, ATA pretreated cells were added to the serially diluted sanguinarine 
in 96 well plates, prior to a further incubation of 2 hrs. Triplicate wells of each drug 
concentration containing 10,000 cells per well were incubated in 37° C + 5% C02 for 2 
hours. The pretreatment of cells with ATA and the subsequent treatment with 
sanguinarine as outlined above, were essential prerequisites for all later experiments. 
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2.3.2.2. Pretreatment of cells with cycloheximide: 
The concentrations ofCHX used were 0.1, 2.5 and 5.0 1-1g/ml. This was dissolved 
in RPMI + 10% FBS. The incubation period for the pretreatment of cells with CHX was 
done in four time periods; 2,12,24 and 48 hrs respectively. These concentrations and time 
periods were obtained by referring to literature (eg. Liu et al., 1994; Yanagihara and 
Tsumuraya, 1992) on this topic, in order to maximize the effect of CHX pretreatment. As 
CHX was not able to inhibit or change the PCD and BCD induced by sanguinarine in any 
significant way, a concentration of 2. 5 1-1g/ml was used with a 2 hr incubation period for 
all subsequent experiments (the selection of a 2 hr incubation period was to be in line 
with a similar incubation period for ATA pretreatment). 
2.4. Quantitative Morphology by light microscopy: 
Sanguinarine was serially diluted in RPMI +I 0% FBS to give a concentration 
range of 25 Jlg/ml to 0.19 llg/ml (8 dilutions) in flat bottom 96 well plates. Cells were 
pretreated with ATA and CHX and exposed to sanguinarine as outlined in the "chemical 
treatment" section. The percentage of cell death (apoptosis or blister cell death) 
corresponding to each drug concentration was determined by quantitative light 
microscopy. Cells with the morphology of apoptosis and BCD were quantitated by 
hemocytometer after 2 hrs. The key morphological criterion of apoptosis was the 
formation of apoptotic bodies and the key criterion for blister cell death was the 
formation of a cell surface blister. 
2.5. Trvpan blue assay: 
Charged cationic dye trypan blue is excluded from live cells with intact plasma 
membranes (Schmid et al., 1992; Schmid et al., 1994). The status of cell viability of 
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K562 cells exposed to ATA, CHX and sanguinarine (as described in the "chemical 
treatment" section) and of untreated controls were evaluated in triplicate, at 10,000 cells 
per well, in flat bottom 96 well plates. These experiments were conducted in triplicate for 
all 8 dilutions of sanguinarine. The exclusion of trypan blue (0.2%) was used as an 
indicator of the number of live cells. After 1 0 minutes of incubation with the dye the 
number of trypan blue excluding cells were counted using a hemocytometer. The 
exclusion of 0.2% trypan blue was used as an indicator of the number of live cells. 
2.6. 51Cr release assay: 
Cell membrane permeability changes were evaluated by Na251Cr04 release assay 
(Liepins et al., 1996). 2 x 106 ofK562 cells were labelled with 200 ~Ci ofNa251Cr04 for 
90 minutes in a humidified incubator at 37°C, 5% C02 . Cells were washed three times 
with PBS + 2% FCS. 
The changes in membrane permeability were evaluated in K562 cells pretreated 
with ATA and CHX, and subsequently treated with sanguinarine (as described in the 
"chemical treatment section), with untreated cells as controls. Experiments were 
conducted in triplicate at 2 x I 04 cells per well and incubated (for two hours with 
sanguinarine) at 37°C using 96 V bottom well plates. The percentage of 51Cr release was 
evaluated by the following formula. 
% Specific 51Cr release: 
(Cells + Sanguinarine) - Spontaneous release x 100 
Maximum 51Cr release- spontaneous release 
Spontaneous :ncr release is the amount of 51Cr released by cells in the absence of the 
drugs. Maximum Cr release is the 51Cr released by exposing the cells to 1N HCI. 
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2.7. Electron Microscopy: 
Serial dilutions of sanguinarine were carried out, (shortly before in vitro use), 
with tissue culture medium [RPMI-1640 + 10% fetal Bovine Serum (FBS)]. Sanguinarine 
was serially diluted in RPM! + 10% FBS to give a concentration range of 25 !J.g/ml to 
0.19 !J.g/rnl (8 dilutions) in flat bottom 24 well plates. Upon exposure of cells to the 
appropriate concentrations of sanguinarine, ATA and CHX (as described in the "chemical 
treatment" section), these and untreated control K562 cells (250000 cells) were spun 
down in microcentrifuge tubes. Then the cells were fixed in situ, in 2% glutaraldehyde, 
post fixed in 1% osmium tetroxide, dehydrated through a series of ethanols and 
embedded in TAAB 812 epoxy resin. Semi thin (0.5 11m) sections were cut axially, 
through all layers of each pellet to select areas for ultramicrotomy. Ultra thin sections 
were stained with lead citrate and 30% alcholic uranyl acetate and then examined in a 
JEOL 1 00-Cx electron microscope (Liepins et al., 1976). 
2.8. "TUNEL" assay: 
Specific 3'-hydroxyl ends of DNA fragments generated by endonuclease-
mediated apoptosis are preferentially repaired by terminal deoxynucleotidyl transferase 
(TdT) (Raghuram et al., 1999; Gorczyca, 1993). The TdT mediated dUTP nick end 
labeling (TUNEL) assay has been developed to label these strand breaks by utilising 
streptovidin-horseradish peroxidase conjugated nucleotides followed by a substrate 
(TBL). This experiment was carried out using the "In Situ Apoptosis Detection Kit" 
(Sigma TACS TM, St. Louis, MO), according to the manufacturer's instructions. 
K562 cells (with and without pretreatment with ATA and CHX) were analyzed 
after two hours of incubation following sanguinarine treatment (as described in the 
«chemical treatment" section). Untreated K562 cells were used as negative controls. 
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Cells were removed from individual wells, washed in PBS and fixed in 10% neutral 
buffered formaldehyde for 10 minutes. Cells were resuspended in 80% ethanol at 1 x 1 06 
cells per mi., from which 50,000 cells were placed onto an electrostatically treated glass 
slide and air dried at room temperature. Cells were then permeabilized with proteinase K. 
Cell samples were then incubated for 60 minutes at 37oC in the presence and absence of 
exogenous TdT and incubated with streptavidin-horseradish peroxidase conjugated 
dNTP, followed by the substrate TBL according to the manufacturer's instructions 
(Sigma T ACS TM In Situ Apoptosis Detection Kit, St. Louis, MO, USA). Cells were 
then examined and photographed under phase microscopy and subsequently accounted 
for, to determine the percentage of TUNEL positive cells to total cells (the extent of 
apoptosis was determined from the appearance of labelled apoptotic bodies). 
2.9. Fluorescein-conjugated annexin V binding assay: 
The annexin V binding status was measured by immunofluorescence microscopy 
and flowcytometry (Zhang et al., 1997; Shounan et al., 1998). After treatment with 
different drug concentrations (as described in the "chemical treatment" section) K562 
cells (1 x 106 cells) were washed with PBS and incubated with annexin v-fluorescein 
isothiocyanate (FITC) conjugate and propidium iodide (PI) using an annexin v-Fluos 
staining kit (Boehringer Mannheim Co.) After labelling, cells were resuspended in 
binding buffer and analyzed using fluorescence microscopy and F ACS analysis. FITC-
fluorescence was measured at 530-545 nm and fluorescence of DNA-PI complexes at 
575-606 nm. Cell debris were excluded from analysis by appropriate forward light scatter 
threshold setting. Four quadrants of the cytograms were set, using negative controls. 
Proportions of cells in each gradient were expressed as the percentage of the total 
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population. The relative cell numbers which showed early apoptotic changes in the form 
of annexin V positive and PI negative cells were shown in a graph. 
2.10. DNA content assay utilizing flow cytometry: 
The DNA content of K562 cells following drug exposure (ATA, CHX, and 
sanguinarine) was analysed using propidium iodide (PI) and flow cytometry (Liepins et 
al., 1996). For this purpose 0.5 x 106 ATA and CHX pretreated K562 cells per well, were 
aliquoted in 12-well plates and exposed to eight serial dilutions of sanguinarine ranging 
from 25 J.Lg/ml down to 0.19 J.Lg/ml for 2 hrs at 37°C. After this time period each well 
received 2.0 ml PBS buffer containing 2.0% formaldehyde and cells were transferred to 
12 x 75 mm tubes, pelleted by centrifugation and the medium removed. Cell pellets were 
treated with 200 J.Ll of ice cold ethanol for 10 minutes and washed twice in PBS buffer 
and treated with RNAase (100 Jlg/ml) for 30 minutes at 37°C, followed by the addition of 
200 J.Ll of propidium iodide (50 J.Lg/ml in 0.6% NP-40 detergent). The fluorescence 
intensity of cells was analysed in a Becton Diclcinson flowcytometer. For each treatment, 
background fluorescence (endogenous fluorescence of sanguinarine) was subtracted from 
mean fluorescence to determine the mean DNA content of cells. 
2.11. Oxvgen consumption measurements: 
Oxygen consumption by K562 erythroleukemia cells under experimental and 
control conditions was measured polarographically using Clark type YSI 5331 oxygen 
sensors in water jacketed, continuously stirred, chambers (model 5301) and digital 
amplifiers (model 16582, Yellow Springs Instrument Company, Inc., Yellow Springs, 
Ohio) as described by Liepins and Hennen, 1977 (Liepins and Hennen, 1977; Liepins and 
Jayasinghe, 1985). The experimental cells were pretreated with ATA and CHX (as 
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outlined earlier) and treated with sanguinarine at 1.5 ~g/ml and 12.5 ~g/ml only inducing 
the morphologies of PCD and BCD, respectively. Temperature in the sample chambers 
was regulated by a continuous flow water bath Poly Temp System (Polyscience, model 
80). The oxygen sensors were calibrated at various temperatures with oxygen saturated 
culture medium at the 'appropriate temperature. Oxygen measurements were carried out 
on 2 ml volumes of medium containing lx 106 K562 cells/mi. Oxygen consumption was 
continually monitored and recorded using two-channel linear recorders. The relative 
oxygen consumption in experimental and control cells were calculated and expressed as 
arbitrary units. 
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3.0. Results 
As described in section 1.12. (objective ofpresent study) a preliminary screen was 
conducted to identify the chemical compounds, that could inhibit PCD and BCD induced 
by sanguinarine in K562 cells. The rationale for selection of these chemical compounds 
was based on their capacity to inhibit apoptosis, as reported in literature. It was also 
described earlier that results of this preliminary screening showed that ATA inhibited 
PCD .almost completely and BCD by 30-40%. Among the drugs that failed to inhibit 
PCD and BCD ~.rere the following: Cyclohexamide, Actinomycin D, Cyclosporine A, 
Glutathione, Butylated hydroxy toluene, Dithiothreitol, Mepacrine, V erapamil, 
Nifedipine, N-acetyl-L-cysteine, pargyline and 3 Aminobenzamide. The results 
documented below pertains to sanguinarine induced PCD and BCD as well as the effects 
of ATA and CHX pretreatment on both these forms of cell death. 
3.1. Light Microscopy and Quantitative Morphology: 
When K562 cells were treated with sanguinarine at concentrations of 1. 5 J..lg/ml 
for 2 hours, the characteristic morphology of apoptosis (formation of apoptotic bodies) 
was evident in >98% of cells [fig. 1A(b)]. Fig. 1A(c) shows the typical morphology of 
blister cell death (the formation of frequently one but rarely two blisters) in >95% of 
cells, when exposed to sanguinarine concentrations of 12.5 J..lg/ml for 2 hours. The 
percentage of PCD and BCD was determined by quantitating apoptotic and blister cells 
using the following morphological criteria: formation of apoptotic bodies for the former 
and single blister formation for the latter. 
Pretreatment of cells with ATA resulted in a complete (- 100%) inhibition of the 
apoptosis [fig. IB(b)] induced by sanguinarine and a reduction ofBCD by about 30-40% 
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[fig. IB(c)]. As shown in fig. lB(a), ATA controls appear not to affect the morphology of 
K562 cells in any measurable way. 
In contrast to ATA pretreatment, the pretreatment of CHX failed to inhibit the 
apoptosis and the blister cell death induced by sanguinarine [figs. IC(b) and IC(c)]. Cells 
treated with CHX only (CHX controls) did not show any changes, as shown in fig. IC(a). 
The graph of figure ID between sanguinarine concentrations inducing PCD and 
BCD in K562 cells and the number of cells undergoing both these fonns of cell death, 
summarizes the above findings. 
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Figure 1 - Light Microscopy and Quantitative Morphology: 
Figure I A: Light microscopy pictures of cells treated with sanguinarine. 
a) Control untreated cells. 
b) Apoptosis induced by sanguinarine. 
c) Blister cell death induced by sanguinarine. 
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Figure lB: Treatment of cells with sanguinarine and ATA. 
a) Cells treated with ATA only (ATA controls) 
b) Cells treated with AT A and sanguinarine (at concentrations that induced apoptosis 
in K562 cells). ATA pretreatment completely inhibited the apoptotic process. 
c) Cells treated with ATA and sanguinarine (at BCD inducing concentrations in 
K562 cells). ATA pretreatment inhibited sanguinarine induced BCD by 30-40%. 
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Figure IC: Treatment of cells with sanguinarine and CHX. 
a) Cells treated with CHX only (CHX controls). 
b) Apoptosis induced by sanguinarine but with CHX pretreatment. Pretreatment with 
CHX failed to inhibit sanguinarine induced apoptosis. 
c) Blister cell death induced by sanguinarine with CHX pretreatment. Pretreatment 
with CHX failed to inhibit BCD. 
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Figure lD: The graph of figure ID between sanguinarine concentrations that induce PCD 
and BCD in K562 cells and the number of cells undergoing both these forms of cell 
death, summarizes the above findings in quantitative morphology. Results show that 
while ATA pretreatment inhibited the morphological characteristics of PCD and BCD 
(albeit, to different degrees), CHX pretreatment failed to do so. 
60 
Q (.) 
Ill 
'tJ 
c 
tel 
0 (.) 
0.. 
en 
c 
0 
~ 
C) 
"C 
c 
~ 
..! 
'i 
... CJ 
0 
~ 
80 
70 
60 
50 
40 
30 
20 
10 
o~~~~--~~~~--~~ 
Cont Sang 1.5 Sang 12.5 
Drug treatment 
61 
D Sanguinarine only 
~~g;~~=;;l A TA+Sanguinarine 
D CHX +Sanguinarine 
3.2. Trypan Blue Exclusion Assay: 
The trypan blue exclusion assay was performed to study cell viability. As shown 
in the graph of fig. 2, between the concentrations of sanguinarine and the percentages of 
cells excluding trypan blue, reveals that all cell samples (controls, sanguinarine induced 
PCD and BCD, and cells pretreated with ATA and CHX) exclude trypan blue, hence 
deemed as viable when assessed by this in-vitro criterion. 
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Figure 2 - Trypan blue exclusion assav: 
The graph of figure 2, between the concentrations of sanguinarine treatment and the 
percentage of cells excluding trypan blue show that all cell samples, whether treated with 
sanguinarine only or pretreated with ATA or CHX excluded trypan blue. 
63 
100~------------, 
Sang 1.5 
drug treatment 
64 
EJ Sanguinarine only 
lmmml A TA+Sanguinarine 
CJ CHX+Sanguinarine 
3.3. 51Cr Release Assay: 
Changes in cell membrane permeability were assessed utilizing the 51Cr release 
assay. 
51Cr release in sanguinarine induced PCD and BCD in sanguinarine treated as 
well as ATA and CHX pretreated cells were studied and presented in a bar graph in fig. 
3. As demonstrated by the graph, the apoptotic cells showed an increase in 51Cr release 
relative to untreated control cells while cells that underwent BCD showed the highest 
increase. Results of cells treated with ATA and sanguinarine show a demonstrable 
decrease in the levels of 51Cr released by cells at concentrations of sanguinarine that 
induce apoptosis. The 51Cr released by treatment of cells with ATA and sanguinarine at 
concentrations inducing BCD too were lower as compared to those of BCD, without 
ATA pretreatment. ATA controls showed a level of 51Cr release that was comparable to 
that of untreated control cells. CHX pretreatment appears not to have changed the basic 
levels of 51Cr release of sanguinarine induced apoptosis and BCD. 
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Figure 3 - 51Cr release assay: 
The graphs in figure 3 show the percentage of 51Cr released vs the cell samples (control, 
PCD and BCD) during sanguinarine treatment only and with ATA and CHX 
pretreatment. Results show a significant rise in 51Cr release during apoptosis and an even 
higher (and more rapid) increase during BCD in cells treated with sanguinarine only 
when compared with untreated control cells. ATA pretreatment appears to inhibit the 51Cr 
released in PCD as well as BCD. ATA controls (ATA pretreatment only) appear to have 
the same levels of 51Cr release as untreated controls. CHX pretreatment appears to have 
had no effect on sanguinarine induced PCD and BCD. 
66 
c:J Sanguinarine only 
mH:Hii~ ATA+Sanguinarine 
Cl CHX +Sanguinarine 
45~------------------------------~ 
"C 
G) 
40 
35 
30 
fd 25 
G) 
! 
.. 
~0 20 
110 
15 
10 
5 
o~~~~~--~~~·~···~· ~~--~~g=gg~~ 
SA1.5 SA 12.5 cont 
drug treatment 
67 
3.4. Transmission Electron Microscopy (TEM): 
The phenomena of apoptosis and BCD induced by sanguinarine were studied 
using transmission electron microscopy. Figs. 4A(a), 4A(b) and 4A(c) show electron 
micrographs of an untreated cell, apoptotic cell and BCD induced by sanguinarine, 
respectively. As shown in fig. 4A(b), morphological changes of apoptosis are evident in 
the apoptotic cell as compared to the normal untreated cell [fig. 4A(a)]. Condensation of 
the cytoplasm with a change in cell shape and size, absence of microvilli, nuclear 
chromatin condensation, cell shrinkage are some of the changes in apoptotic cells. 
Chromatin condensation is evident at the periphery of the nucleus with the areas of 
condensed chromatin acquiring a concave shape, with a uniform and smooth appearance. 
Nuclear fragmentation or karyorrhexis and the presence of apoptotic bodies are also 
evident in sanguinarine induced apoptosis. These apoptotic bodies contain nuclear 
fragments and cellular organelles. The plasma membrane also show blebbing (resembling 
budding in yeast) on the surface of cells. Fig. 4A(c) shows a cell that has undergone 
BCD. Cellular swelling and blister formation are evident in BCD, along with patchy 
chromatin condensation and vacuolization of the cytoplasm. The prominent single blister 
(rarely two) is devoid of organelles. 
Figs. 4B(a), 4B(b) and 4B(c) display cells pretreated with ATA. ATA 
pretreatment causes a complete inhibition of the blebbing and shedding of membrane 
vesicles in sanguinarine induced apoptosis and a partial inhibition of single blister 
formation of BCD. Fig. 4B(a) shows an electron micrograph of a control cell treated with 
ATA only, while Fig. 4B(b) and 4B{c) show cells treated with ATA plus sanguinarine at 
concentrations that induce apoptosis and at concentrations inducing BCD, respectively. 
As evident from fig. 4B(a), ATA pretreatment alone (ATA controls) appeared to have no 
significant effect, as compared to untreated control cells [Fig. 4A(a)]. Fig. 4B(b) show 
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the inhibition of apoptosis with the absence of both apoptotic bodies and nuclear 
fragmentation. However, a slight increase in chromatin condensation and cytoplasmic 
vacuoles were observed, as compared to sanguinarine induced apoptosis. The presence of 
microvilli was also noted in ATA pretreated cells. Fig. 4B(c), on the other hand, show the 
absenceofblister formation (although it should be noted that ATA pretreatment inhibited 
BCD only by about 30-40%). Patchy chromatin condensation and an increase in the 
cytoplasmic vacuoles are also seen along with an absence of microvilli. 
As displayed in Figs. 4C(b) and 4C( c), the pretreatment of CHX had no effect on 
sanguinarine induced apoptosis and BCD respectively, while fig. 4C(a) demonstrates that 
CHX exposure alone (CHX controls) does not lead to any significant change in cell 
morphology. 
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Figure 4- Electron Micrographs (magnification 3000 x 3): 
Figure 4A: Transmission electron microscopy pictures of cells treated with sanguinarine 
only. 
a) 
b) 
Control untreated cell 
Apoptotic cell induced by sangumanne. Apoptotic bodies contain nuclear 
fragments, cellular organelles and concave shaped chromatin condensation. 
Microvilli are not present in apoptosis. 
c) :Blister cell death in a cell induced by sanguinarine. The large blister is devoid of 
organelles. The nucleus show swelling (unlike the fragmentation of apoptosis) 
along with nuclear condensation. An increase in the number of vacuoles is also 
prominent. 
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Figure 4B: Transmission electron microscopy graphs of ceiis treated with ATA and 
sanguinarine. 
a) Cell treated with ATA only. AT A pretreatment does not appear to have any 
significant effect on cell morphology. 
b) Cell treated with ATA and sanguinarine (at concentrations that induce apoptosis 
in K562 cells). Cells show an inhibition in the formation of apoptotic bodies and 
nuclear fragmentation. 
c) Cell treated with ATA and sanguinarine (at concentrations that induce BCD in 
K562 cells). The cell shows no blister formation although only 30-40% of cells 
displayed this inhibition. An increase in vacuoles is noted while microvilli were 
conspicuous by their absence. 
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Figure 4C: Transmission electron microscopy graphs of cells treated with CHX and 
sanguinarine 
a) Cell treated with CHX only. CHX pretreatment appears to have no effect on cell 
morphology. 
b) Apoptotic cell induced by sanguinarine, pretreated with CHX. CHX pretreatment 
appears to have no effect on the morphology of the apoptosis of sanguinarine. 
c) BCD induced by sanguinarine, pretreated with CHX. CHX pretreatment seems to 
have no effect on BCD inhibition either. 
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3.5. "TUNEL" Assay: 
The Terminal Deoxyribonucleotidyl Transferase Mediated dUTP Nick End 
Labelling Assay for the detection of DNA fragmentation (nicking) was done in control 
and sanguinarine treated cells. Figs. 5A, 5B and 5C show the results of the "TUNEL" 
(TdT mediated dUTP nick end labelling) assay in light micrographs. While Fig. 5A 
shows the results in sanguinarine induced PCD and BCD, fig. 5B shows the effects of 
AT A pretreatment and fig. 5C the effects of CHX pretreatment on these two forms of cell 
death. 
Sanguinarine induced apoptosis displayed a positive "TUNEL" assay [Fig. 5A(b)] 
denoting DNA nicking, while, control untreated cells displayed a negative "TUNEL'' 
assay [Fig. 5A(a)]. Fig. 5A(c) show a negative "TUNEL" displayed by sanguinarine 
induced BCD. 
Fig. 5B(b) showed a negative "TUNEL" in cells treated with ATA and 
sanguinarine at concentrations inducing apoptosis, denoting an inhibition in DNA nicking 
ofthis form ofapoptosis. Figs. 5B(a) and 5B(c) shows negative "TUNEL" for ATA only 
(ATA controls) and ATA and sanguinarine (at concentrations inducing BCD) treated 
cells respectively. 
Figs. 5C(a) and 5C(c) display negative "TUNEL", while the result of 5C(b) is 
positive. Fig. 5C(a) show CHX only (CHX controls) treated cells, while fig. 5C(b) show 
cells treated with CHX and sanguinarine at apoptosis inducing concentrations and fig. 
5C( c) show CHX and sanguinarine at BCD inducing concentrations. 
The graph of figure . 5D between sanguinarine concentrations inducing PCD and 
BCD and the percentage of TUNEL positive cells in both these forms of cell death, 
summarizes the above findings. 
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Figure 5- "TUNEL" Assay: 
Light micrographs of the results of the "TUNEL" (TdT mediated dUTP nick end 
labelling) assay to detect DNA strand breaks. The dark spots within the cells denote a 
positive "TUNEL''. 
Figure SA: Pictures of cells treated with sanguinarine. 
a) Untreated control cells show negative "TUNEL". 
b) Apoptotic cells treated with sanguinarine show positive "TUNEL". 
c) BCD induced by sanguinarine (at 12.5 Jlg/ml) show negative "TUNEL". 
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Figure 5B: Pictures of cells pretreated with ATA and then exposed to sanguinarine. 
a) Cells treated with ATA only show negative "TUNEL''. 
b) Cells treated with ATA and sanguinarine (at concentrations inducing apoptosis in 
K562 cells) show negative "TUNEL". 
c) Cells treated with ATA and sanguinarine at concentrations inducing BCD show 
negative "TUNEL". 
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Figure 5C: Pictures of cells pretreated with CHX and then exposed to sanguinarine. 
a) Cells treated with CHX only. "TUNEL" negative. 
b) Apoptotic cells treated with CHX and sanguinarine. "TUNEL" positive. 
c) BCD cells treated with CHX and sanguinarine. 'TUNEL" negative. 
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Figure SD: The graph of figure 5D between sanguinarine concentrations that induce PCD 
and BCD and the percentage of TUNEL positive cells in both these forms of cell death, 
summarizes the above findings. Results show that while AT A pretretment appears not to 
have any significant effect on the TUNEL results of BCD, it certainly shows an inhibition 
of DNA nicking observed during sanguinarine induced PCD. The outcome of TUNEL 
during sanguinarine treatment remained unchanged despite CHX pretreatment. 
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3.6. Annexin V- Fluorescence Microscopy: 
The light micrographs of Fig. 6 show the results of the annexin V assay, utilized 
to assess the phosphotidyl serine flip. Fig. 6A shows the results of cells that underwent 
sanguinarine induced cell death (PCD and BCD), Fig. 6B shows the results of cells 
treated with AT A and sanguinarine while Fig. 6C shows the results of cells treated with 
CHX and sanguinarine· (the green fluorescence denotes the occurrence of the 
phosphatidyl serine (PS) flip, while the yellow nuclear fluorescence is due to 
sanguinarine). 
As shown, while untreated control cells had a negative result [Fig. 6A(a)] the 
apoptotic cells induced by sanguinarine were positive for the phosphatidyl serine flip 
[Fig. 6A(b)]. Sanguinarine induced BCD showed a negative result [Fig. 6A(c)]. 
Fig. 6B(b) representing ATA and sanguinarine treated cells at doses of 1.5 Jlg/ml 
(concentrations inducing apoptosis in K562 cells) did not show the PS flip. ATA controls 
and cells treated with ATA and sanguinarine at doses of 12.5 Jlg/ml (concentrations 
inducing BCD in cells), shown in figs. 6B(a) and 6B(c) respectively, did not demonstrate 
a positive phosphotidyl serine flip. 
Figs. 6C(a), 6C(b) and 6C(c) represents CHX pretreated cells. While apoptosis 
[fig. 6C(b)] showed a positive annexin V, BCD [fig. 6C(c)] and CHX controls [fig. 
6C(a)] showed negative results. 
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Figure 6 - Annexin V- Fluorescence Microscopy: 
Light micrographs of the results of the annexin v assay utilized to study the phosphatidyl 
serine flip . The green fluorescence identifies cells that were positive for the phosphatidyl 
serine flip and is located on the cell surface. The bright yellow observed in some cells are 
the result of the fluorescence of sanguinarine in the nuclei . 
Figure 6A: Light micrographs of cells treated with sanguinarine. 
a) Untreated control cells. Negative annexin V. 
b) Cells treated with sanguinarine at 1.5 IJ.g/ml. Positive annexin V. 
c) Cells treated with sanguinarine at 12.5 IJ.g/ml for 2 hrs. Negative annexin V. 
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Figure 6B: Light micrographs of cells pretreated with ATA and then exposed to 
sangumanne 
a) Cells treated with ATA only. Negative annexin V. 
b) Cells treated with ATA and sanguinarine at concentrations inducing apoptosis. 
Negative annexin V. 
c) Cells treated with ATA and sanguinarine at concentrations that induce BCD. 
Negative annexin V. 
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Figure 6C: Light micrographs of cells pretreated with CHX and then exposed to 
sanguinarine. 
a) Cells treated with CHX only. Negative annexin V. 
b) Cells treated with CHX and sanguinarine at concentrations inducing apoptosis. 
Positive annexin V. 
c) Cells treated with CHX and sanguinarine at concentrations inducing BCD. 
Negative annexin V. 
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3.7. Annexin V Assay- Flow cytometry: 
The results of the annexin V assay were also assessed by flowcytometry. The bar 
graph as shown in Fig. 7 displays the percentage of annexin v binding in cells. An 
increase in annexin V binding was observed in the apoptosis induced by sanguinarine and 
also in the cells pretreated with CHX that underwent apoptosis. As shown, all other cell 
samples (untreated controls, sanguinarine induced BCD, ATA controls, ATA and 
sanguinarine treated, CHX controls and CHX and sanguinarine treated at concentrations 
inducing BCD) did not show any significant annexin v binding. 
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Figure 7- Annexin V-Flow cytometrv: 
The graph between the percentage of annexin V positive cells and the various cell 
samples (control, PCD and BCD), show the quantitation of the phosphatidyl serine flip 
by F ACS analysis using annexin V. These results confirm the above fluorescence 
microscopy results. The phosphatidyl serine flip was positive in apoptotic cells of 
sanguinarine and in apoptotic cells induced by sanguinarine but with CHX pretreatment. 
All other cell samples showed negative annexin V. 
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3.8. Cellular DNA Content-Flow cytometry: 
The DNA content in cells was assessed using flow cytometric analysis. The DNA 
histogram of Fig. 8 shows the DNA content versus the number of cells. 
The DNA content of untreated control cells, apoptotic cells induced by 
sanguinarine and cells that underwent sanguinarine induced BCD was assessed (Fig. 8A). 
While apoptotic cells show no change in DNA content (comparable with control 
untreated cells), the cells that underwent BCD display a shift to the right denoting an 
apparent increase in DNA content. 
A histogram reflecting the DNA content of cells pretreated with ATA and 
subsequently exposed to sanguinarine is shown in Fig. 8B. Results show that while ATA 
pretreatment had no effect on the DNA content in cells treated with apoptosis-inducing 
concentrations of sanguinarine, ATA pretreatment reduced the shift to the right, which 
was observed during BCD. The DNA content of AT A controls was comparable to that of 
untreated control cells. 
A DNA histogram of the flow cytometric analysis of DNA content in cells 
pretreated with CHX and subsequently exposed to sanguinarine is shown in Fig. 8C. 
Results showed that CHX pretreatment had no effect on the DNA content induced by 
sanguinarine, i.e., while the DNA content level shifted to the right in BCD, there was no 
change in PCD as compared to CHX controls. CHX controls showed a DNA content 
level comparable to that of untreated control cells. 
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Figure 8- Cellular DNA Content- Flow cytometrv: 
Flow cytometry analysis of DNA content by histogram using propidiurn iodide. 
Figure 8A: Histogram ofuntreated cells and cells treated with sanguinarine. Results show 
increased DNA content in BCD but not in apoptosis. 
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Figure 8B: Histogram of cells pretreated with ATA and then exposed to sanguinarine. 
While ATA pretreatment reduced the characteristic shift to the right ofBCD, it had no 
effect on the DNA content ofPCD. 
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Figure 8C: Histogram of cells pretreated with CHX and then exposed to sanguinarine. 
CHX pretreatment appears to have no effect on DNA content neither of PCD nor of 
BCD. 
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3.9. 0~ Consumption Studies: 
The results of this study, designed to investigate the 02 consumption rates of 
cells, are depicted in Fig. 9. These 02 consumption graphs show 0 2 consumption rates by 
cells versus time. 
Fig. 9A shows the results of 02 consumption studies of untreated control cells, 
apoptotic cells and in cells that underwent BCD induced by sanguinarine. Untreated 
control cells showed a linear 0 2 consumption rate during the first two hours. The cells 
that underwent apoptosis showed an accelerated rate of 0 2 consumption with time, 
followed by a rapid decline. The first 30 minutes of exposure to sanguinarine showed a 
relatively sharp increase in the 0 2 consumption rate over that of controls, followed by a 
rate comparable to that of controls between 30-60 minutes and a rate lower than that of 
controls between 60-120 minutes. In sharp contrast, cells that underwent BCD displayed 
comparatively lower rates of02 consumption after the first 30 minutes. 
Fig. 9B shows the results of02 consumption studies of cells pretreated with AT A 
ATA pretreatment increased the 0 2 consumption rates overall, in both sanguinarine-
induced apoptosis and BCD. However, as opposed to sanguinarine induced apoptosis, 
ATA pretreatment prevented the accelerated oxygen consumption during the initial half-
hour of sanguinarine exposure. The 0 2 consumption rate of ATA controls (cells treated 
with ATA only) showed an 0 2 consumption rate similar to untreated controls. 
Fig. 9C showed the results of 0 2 consumption studies of cells pretreated with 
CHX. CHX pretreatment appears to have no significant effect on 0 2 consumption rates of 
sanguinarine induced PCD and BCD. The 0 2 consumption rates of CHX controls (cells 
treated with CHX only) were similar to that of untreated controls. 
108 
Figure 9 - Graphs depicting 0~ consumption levels with time: 
Figure 9A: Graph showing 02 consumption levels in arbitrary units with time in 
untreated controls, apoptotic cells induced by sanguinarine and in cells that underwent 
sanguinarine induced BCD. The apoptotic cells showed an initial rapid phase of 
accelerated oxygen consumption (especially in the first half-hour of sanguinarine 
exposure), and later a slowing down and gradually tapering off at 2 hours. In contrast, the 
control untreated cells adopted a steady rate of oxygen consumption and continued 
beyond the second hour. BCD tends to have a fairly even rate for the first half-hour, after 
which the rate declines rapidly. 
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--.- Sanguinarine Control 
--•-- Sanguinarine PCD+ 
-~- Sanguinarine BCD+ 
Figure 9B: Graph showing 02 consumption rates in cells treated with ATA only (ATA 
controls) and cells pretreated with ATA and later exposed to concentrations of 
sanguinarine inducing apoptosis and BCD. As opposed to sanguinarine induced 
apoptosis, ATA pretreatment did not show the accelerated oxygen consumption rate 
during the initial half hour of sanguinarine exposure nor did it show the slowing down of 
the oxygen consumption rate which was seen in cells treated with sanguinarine only. The 
oxygen consumption rate was almost similar to that of untreated controls. 
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Figure 9C: As shown in this graph CHX pretreatment appear to have no effect on the 02 
consumption rates of sanguinarine induced PCD and BCD. 
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4.0. DISCUSSION 
Previous studies in our laboratory demonstrated that K562 cells when exposed to 
sanguinarine, display the classical morphology of apoptosis at 1.5 !J.g/ml and the 
morphology ofBCD at 12.5 !J.g/ml, when observed by light microscopy. When pretreated 
with different concentrations of ATA for various time periods (as outlined in "methods") 
it was found that ATA pretreatment at 100 !J.M for 2 hrs· completely inhibited the 
morphology of sanguinarine induced apoptosis, while the number of cells demonstrating 
the morphology ofBCD was reduced by 30-40%. 
Apoptosis is generally been found to correlate with DNA fragmentation ( Liepins 
and Younghusband, 1987) and is considered to be the hallmark ofapoptosis (Arends et 
al., 1990; Compton, 1992 ). This DNA fragmentation is thought to occur at the 
internucleosomal regions due to the activation of a specific endonuclease (Barry and 
Eastman, 1993, Majno and Joris, 1995, Arends et al., 1990, Comrnpton, 1992, Wyllie et 
al., 1992). Not all cells, however, manifest a strict correlation between the morphology of 
apoptosis and nuclear DNA fragmentation (Ucker et al., 1992). Initially, DNA is cleaved 
at the sites of attachment of chromatin loops to the nuclear matrix, which results in the 
appearance of discrete 300-50 kb size fragments (Oberhammer et al., 1993). 
Subsequently, DNA is preferentially cleaved between nucleosomes. The products are 
discontinuous DNA fragments representing nucleosomal and oligonucleosomal sized 
DNA fragments. They generate a characteristic "ladder" pattern during agarose gel 
electrophoresis. However, in many cell types, DNA cleavage during apoptosis does not 
proceed to inter-nucleosomal sized sections but rather proceeds only to 300-50 kb size 
DNA fragments (Oberhammer et al., 1993; Cohen et al., 1992; Collins et al. 1992; 
Ormerod et al., 1994; Zakeri et al. , 1993; Zamai et al. , 1996). Thus, it should be stressed 
that, because in many cell types DNA degradation during apoptosis does not progress to 
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internucleosomal segments but stops at 300-SOkb fragments, the absence of the former 
segments (no ''DNA laddering") is not evidence of the lack of apoptosis. The presence of 
a large number of DNA strand breaks is a very specific marker of apoptosis (Gorczyca et 
al., 1992). Their detection, by the assay employing exogenous TdT, has therefore, 
become one of the main criteria in studies of cell death. The reaction catalyzed by 
exogenous TdT ("end labeling", ''tailing", "TUNEL") or DNA polymerase (nick 
translation) is aimed at detecting the 3' OH ends in DNA breaks by attaching to them 
biotin or digoxygenin conjugated nucleotides ( Gorczyca et al., 1992; Gorczyca et al., 
1993; Li et al. 1996 ). Previous studies in our laboratory showed a lack of DNA 
fragmentation in sanguinarine induced apoptosis, analyzed by standard agarose gel 
electrophoresis (Liepins et al., 1996). The "TUNEL" assay to reveal the presence of DNA 
fragmentation in the apoptosis induced by sanguinarine showed nicking of DNA strands. 
When pretreated with ATA, apart from an inhibition of the morphology of apoptosis, a 
negative "TUNEL" denoting lack of DNA strand fragmentation was also observed. 
Inhibition of DNA strand nicking may be in conformity with the endonuclease inhibiting 
function of ATA (Hallick et al., 1977 ). 
The remaining results of the present study pertaining to the parameters of 
apoptosis, confirms the above notion of the inhibition of apoptosis induced by 
sanguinarine, by ATA. Results of light and electron microscopy studies show the lack of 
formation of apoptotic bodies and nuclear fragmentation when pretreated with AT A, 
despite having a marginal increase in vacuoles and a degree of patchy chromatin 
condensation. AT A pretreatment resulted in a decrease in membrane permeability as 
well, denoted by a decrease in the 51Cr released, as opposed to the concomitant release of 
51Cr in apoptosis. The absence of the phosphatidyl serine flip demonstrated by a negative 
annexin V assay in ATA pretreated cells, was in sharp contrast to that of apoptosis 
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induced by sanguinarine. As opposed to the oxygen consumption rates of sanguinarine 
induced apoptosis, ATA pretreatment did not show the accelerated oxygen consumption 
during the initial half hour of sanguinarine exposure nor did it show the the tapering off 
of it at 2 hrs of sanguinarine exposure. The high oxygen consumption rates (during the 
first half hour) associated with the sanguinarine induced apoptotic process in the present 
study may represent elevated levels of cellular respiration providing the energy required 
for the apoptotic process. These results were in keeping with earlier observations in our 
laboratory of significantly higher oxygen requirements of apoptotic mastocytoma P815 
cells than nonapoptotic cells in cold shock induced apoptosis (Liepins et al., 1985). 
Alternatively, the fonnation of reactive oxygen intermediates, reported to play a role in 
some cytolytic processes, may account for some or all of the elevated oxygen 
consumption rates (Nathan et al., 1982; Keisari et al., 1984; Guthrie et al., 1984). 
Whereas, the tapering off, of the oxygen consumption rates (denoted by the plateauing of 
the curve in fig. 8) at the end of the 2 hr period of sanguinarine exposure, may indicate 
the dying process. The initial reduction coupled with the subsequent stabilization of 
oxygen consumption rates when pretreated with AT A is in consonance with the inhibition 
of the sanguinarine induced apoptotic process. 
Conversely, pretreatment of cells with the protein synthesis inhibitor 
cyclohexamide (CHX), failed to inhibit the apoptosis induced by sanguinarine. This is 
confirmed by the results of light and electron microscopy, "TUNEL", 51Cr release, 
annexin V and oxygen consumption assays. Failure to inhibit sanguinarine induced 
apoptosis by cycloheximide may have been due to, either protein synthesis not being a 
factor in the apoptosis induced by this drug or that the 2 hour exposure to the drug not 
being adequate to exercise the capacity of cycloheximide to inhibit protein synthesis and 
consequently, to inhibit the apoptotic process. This notion is corroborated by recent 
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findings in our laboratory utilizing western blotting technics and eDNA expression 
arrays. Apoptotic cells analyzed by western blotting technics showed an increase in the 
pro-apoptotic protein Bax and a decrease in the anti apoptotic gene products of Bcl-2 and 
NFkB (Weeresinghe et al., in preparation), while eDNA expression studies showed no 
changes in mRNA levels pertaining to these gene products. 
These results suggest that, while ATA successfully counteracted the apoptosis 
induced by sanguinarine, CHX failed to do so. Thus, even though protein synthesis 
inhibition has been reported to be effective in the inhibition of apoptosis in certain 
experimental conditions (Williams et al., 1990; Yanagihara et al., 1992; Wyllie et al., 
1987), this appears not to be the case in sanguinarine induced apoptosis ofK562 cells. On 
the other hand, the inhibition of endonuclease by AT A (Hallick et al. 1977) was 
successful in inhibiting the apoptotic process induced by sanguinarine. Thus, it could be 
assumed that, rather than de novo protein synthesis, what is more important for the 
sanguinarine induced apoptotic process is the post-translational modification of the 
already synthesized proteins. 
The effects of CHX on apoptosis may depend on many factors including the cell 
death inducing agent, its dose and the type of cell line (Yanagihara et al. 1992). 
Yanagihara et al., reports inhibition of apoptosis induced by TGF-f31 (transforming 
growth factor f31) in human gastric scirrhous carcinoma cell lines HSC-39 and HSC-43 by 
CHX. This might suggest the requirement for new protein synthesis in TGF-f31 induced 
cell death. At the same time, the authors assert that, the pretreatment of CHX had no 
effect upon TGF-P1 mediated hepatoma cell death. The authors also claim that, at lower 
TGF-f31 concentrations, CHX partially prevented TGF-P1 induced cell death in a dose 
dependent fashion (Yanagihara et al., 1992). Evidence of CHX acting as a stimulant of 
apoptosis is also found in literature (Thomas and Hersey, 1998). 
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The phenomenon of single blister formation or BCD is at best, only poorly 
reported in literature. As previously mentioned, this phenomenon of BCD is induced 
when K562 cells were treated with sanguinarine concentrations of 12.5J.Lg/ml for 2 hrs. 
Cell surface blister formation in hepatocytes induced by hypoxia has been reported to 
produce blebbing and/or blister formation in more than 70% of cells (Lemasters et al. 
1987). This morphology was found to be independent of intracellularlar calcium fluxes, 
and the rupture of these large cell surface blebs was considered by the authors to 
represent the abrupt transition from reversible to irreversible cell injury. 
As opposed to apoptosis induced by sanguinarine, BCD was characterized by a 
negative "TUNEL" assay denoting the absence of DNA nicking, a negative annexin V 
assay showing the absence of the phosphatidyl serine flip and a DNA content analysis by 
flowcytometry with a shift to the right denoting increased ploidy. Roberts et al., reports 
that taxol induces a nominal degree of polyploidy in K562 cells when treated with a 
concentration of 10 J.1M for 24 hrs, although there had been no indication of any degree of 
cell ploidy at short term intervals, i.e., four hours (Roberts et al., 1990). Membrane 
permeability assessment of BCD in the present study by 51Cr release assay showed a 
much higher release than that of apoptosis while oxygen consumption studies showed a 
consumption rate much lower and distinctly different to that of apoptosis. These results 
also denote that BCD is a cell death process with reduced levels of energy. This is in 
sharp contrast to sanguinarine induced apoptosis, which presumably, is a higher energy 
requiring process as shown by a higher oxygen consumption rate at least during it's initial 
stages. The earlier plateauing of the oxygen consumption curve in BCD (fig. 9) also 
suggests that mitochondrial dysfunction occurs much earlier than that of apoptosis. 
Electron microscopic studies show cytoplasmic swelling by way of blister formation, 
nuclear swelling sans the nuclear fragmentation of apoptosis and patchy chromatin 
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condensation. However, it was also shown that cells, which underwent BCD, excluded 
trypan blue indicating cell viability and a functional cell membrane. The exclusion of 
trypan blue by the cell membrane shows that BCD is not representative of early necrosis 
(Wyllie et al., 1984 ). It is generally accepted that necrosis does not indicate a form of cell 
death but refers to changes secondary to cell death by any mechanism (Majno and Joris, 
1995). These characteristics of BCD may point to it being representative of an early stage 
of oncosis. Oncosis is deemed to be a part of accidental cell death accompanied by 
swelling (Majno and Joris, 1995). Thus, BCD could be hypothetically construed as an 
early stage of oncosis. Accordingly, this may also serve as a future "model" for the study 
ofoncosis. 
When pretreated with ATA, sanguinarine induced BCD was reduced by 30-40% 
as assessed by light microscope while CHX pretreatment of cells had no effect on its 
reduction. Thus, it could be asserted that, while the inhibition of protein synthesis plays 
no role in BCD, the inhibition of endonuclease appears to retard the BCD process. ATA 
pretreatment in BCD also show a relative increase in oxygen consumption, decrease in 
51Cr release and a decrease in DNA content or ploidy as compared to BCD without ATA 
pretreatment. These results point to an inhibition of sanguinarine induced BCD during 
ATA pretreatment of cells. 
Further studies are warranted to determine the molecular changes of ATA 
pretreatment in BCD, with a view to demystifying the partial inhibition of it during ATA 
pretreatment. ATA pretreatment of cells appeared to have no effect in transmission 
electron microscopic, TUNEL, as well as annexin V studies when compared to BCD 
without ATA pretreatment. Contrary to ATA, CHX pretreatment appears not to effect 
any of the parameters of sanguinarine induced BCD. Thus, similar to the assumptions 
made regarding the failure of CHX to inhibit apoptosis, it could be argued that, either this 
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process of sanguinarine induced BCD does not necessitate protein synthesis or that the 2 
hr period of sanguinarine exposure does not provide sufficient time for the protein 
synthesis inhibiting process of CHX to take effect. 
Another noteworthy feature observed during the induction of BCD, was the 
intensity of the sanguinarine auto-fluorescence itself. This is demonstrated in the 
fluorescence light microscopic pictures of fig. 6, designed to detect the phosphatidyl 
serine flip in the annexin V assay. Fig. 6A shows the yellow fluorescence of sanguinarine 
(which incidentally, also happens to fall within the green fluorescence range) during 
BCD [fig. 6A(c)] but absent during apoptosis [fig. 6A(b)](which shows only the green 
fluoresence of FITC conjugated annexin V). The spectre of an increased presence of 
sanguinarine in BCD may be at least partly responsible for the tumor cell killing ability 
of this anti-cancer drug. This assumption is fortified by the fact that sanguinarine 
exercises it's anti-cancer properties (Sen and Maiti, 1994; Babich et al., 1996), among 
other probable mechanisms of actions, by forming a molecular complex with DNA 
through intercalation; more specifically, by binding to regions rich in guanosine-cytosine 
(Sen and Maiti, 1994; Babich et al., 1996). Previous studies in our laboratory have also 
confirmed that sanguinarine overcomes the multi-drug resistant (.MDR) phenomenon, in 
the Pgp positive MDR CEM-VLB human leukemia cell line (Liepins et a!., 1996 
(abstract); Weerasinghe et al., in preparation). Therefore, the overcoming of the MDR 
phenomenon by sanguinarine could hypothetically be associated with the induction of 
BCD. Thus, the efficacy of sanguinarine as an effective anti-cancer agent could well be 
the result of the induction of BCD, in addition to the usual PCD, which is widely reported 
in literature. It has been stated that apoptosis is only rarely observed in vivo and may not 
be the sole cell death mechanism and that this observation emphasizes the need to explore 
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new forms of cell death mechanisms (Houghton, 1999). In view of this grave necessity to 
identify new forms of cell death, the phenemenon of BCD looms large. 
The present study attempted to shed more light on some of the biochemical 
mechanisms of sanguinarine induced PCD and BCD, while revealing multiple parameters 
of both these forms of cell death in a tumor cell line. It has been reported that, the 
efficacy of anti-cancer drugs may hinge on their ability to alter the apoptotic regulatory 
machinery of cancer cells (Earnshaw et al. 1999). In keeping with this statement by 
Earnshaw et al., it might be equally compelling to assume that unravelling the molecular 
make-up of BCD might bear fruit in terms of better comprehending the role of BCD in 
tumqr cell killing. This might even lead to a better understanding of chemo-resistance and 
the ability to overcome this monumental obstacle to finding a cure for cancer. 
The discovery of new and effective anti-cancer agents and unraveling their 
mechanisms of action is an important step in the war against cancer. Knowledge of 
mechanisms of action of drugs could help device a formula for the more efficient and 
judicious use of these agents as combination therapy with other more established 
therapeutics for the effective treatment of drug resistant forms of cancer. 
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